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ABSTRACT 
Lewy bodies are intracytoplasmic aggregates that are the major pathological 
feature of Parkinson’s disease (PD). Their primary protein component, α-synuclein (α-
syn), adopts an amyloidogenic fibrillar form in Lewy bodies.  In recent years research has 
slowly started to unravel clear pathological links between this fibrillar protein and PD 
disease progression. While great progress is being made, it has become evident that the 
structures of different α-syn fibril forms are closely linked to their pathogenicity, and the 
lack of structural details have hindered our understanding of PD.  
Here, I present the first 3D structure of α-syn fibrils determined through solid-
state NMR spectroscopy experiments validated with X-ray fiber diffraction and electron 
microscopy mass per-length measurements. The fibril form presented here is shown to be 
pathologically active in neuronal cell culture. Further, the structure is validated by 
comparison of the structure to three of the early-onset PD mutants, A30P, E46K, and 
A53T, and show that the changes in the SSNMR spectra induced by the mutation are 
consistent with the structural features present in the fibril, most notably the E46K mutant 
disrupting a stabilizing salt-bridge within the fibril core. Additionally, I show that non-
native cysteine mutants of T33C, V48C, T59C, A85C, and Q99C further validate the 
structure. The results and studies presented here establish the first structure of α-syn 
fibrils and provide the experimental and computational basis for greatly increasing our 
understanding of PD, amyloid fibril structure, and advancing the techniques available for 
structural studies via SSNMR spectroscopy. 
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CHAPTER 1: 
INTRODUCTION 
 
1.1 Preface 
Lewy bodies and Lewy neurites are intracytoplasmic aggregates that have long 
been the characteristic pathological feature of Parkinson’s disease (PD). Since its 
identification as the primary proteinaceous component of Lewy bodies in 1997, α-syn has 
become a protein of intense interest for understanding the pathology of PD. A presynaptic 
protein of poorly understood function, α-syn adopts an amyloidogenic (fibrillar) form in 
Lewy bodies, and it is only in the last several years that research has slowly started to 
unravel clear pathological links between this fibrillar protein and PD disease progression. 
While great progress is being made, it is becoming extremely evident that the precise 
structure of different α-syn fibril forms are closely linked to their pathogenicity, and the 
lack of structural details have greatly hindered our understanding of PD.  
As an amyloid fibril, α-syn has proven to be a particularly challenging structure 
to obtain. Amyloid fibrils are unique biopolymers that, as insoluble and non-crystalline 
solids, are not amenable to classic structural studies using X-ray diffraction or solution-
state NMR. While solid-state NMR spectroscopy (SSNMR) has established as an 
invaluable tool for the study of complex biomolecules such as α-syn, amyloid fibrils 
contain many structural features that distinguish themselves from classic globular and 
membrane proteins that present challenges in traditional structure determination 
methodologies.  
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Here, I present a high-resolution 3D structure of α-syn fibrils determined through 
a combination of magic-angle spinning solid-state NMR spectroscopy experiments 
validated with X-ray fiber diffraction and electron microscopy mass per-length 
measurements. Further, the fibril form presented here is shown to be pathologically active 
in neuronal cell culture. From 68 multidimensional spectra collected from samples with 
six isotopic labeling patterns, over 7,500 cross peaks were assigned, including 210 unique 
long-range restraints that define a consensus structure. The fibril structure adopts a novel 
Greek-key topology within a β-serpentine arrangement containing parallel in-register β-
sheets, complementary sidechain packing, an intermolecular salt bridge, intermolecular 
hydrogen bond interactions, and a hydrophobic core. These structural insights may 
facilitate an improved understanding of α-syn fibril nucleation, propagation, and 
interactions with small molecules in order to diagnose and treat PD. 
 Further, the structure is validated by comparison of the structure to three of the 
early-onset PD mutants, A30P, E46K, and A53T, and show that the changes in the 
SSNMR spectra induced by the mutation are consistent with the structural features 
present in the fibril, most notably the E46K mutant disrupting a stabilizing salt-bridge 
within the fibril core. Additional non-native cysteine mutants of T33C, V48C, T59C, 
A85C, and Q99C further validate the structure by showing that those residues in highly 
disordered or dynamic regions, such as T33C, T59C, and Q99C have little impact on the 
fibril fold, while A85C causes local perturbations. Finally we show that interrupting a 
key structural interaction by the V48C mutant prevents the fibrillization process for 
greater than three weeks. The results and studies presented here establish the first 
structure of α-syn fibrils and provides the experimental and computational basis for 
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greatly increasing our understanding of PD, amyloid fibril structure, and advancing the 
techniques available for structural studies via SSNMR spectroscopy. !
1.2 Introduction 
Since its identification as the primary component in Lewy Bodies1, the pathological 
hallmark of Parkinson’s disease (PD), α-synuclein (α-syn) has become a protein of 
intense research, with more than 23,000 papers published on the link between α-syn and 
PD (according to Web of Science, October 2015). While there is still a lack of detailed 
understanding as to the pathological role that α-syn serves in PD, in recent years results 
have emerged that begin to show the role of α-syn fibrils in the initiation and propagation 
of pathology, both in vitro and in vivo2-7. In a landmark study, Luk et al. (Virginia Lee 
laboratory, U. of Pennsylvania) showed for the first time that a single inoculation of pre-
formed α-syn fibrils into non-transgenic mice results in cell-to-cell transmission of 
phosphorylated α-syn, long believed to be the pathological form of the fibrils (Fig. 1.1)5. 
This transmission led to the formation of Lewy-like pathology in the mice and 
recapitulates the neurodegenerative cascade consistent with PD. Further studies from the 
Lee lab identified additional fibril forms, with differing conformations based on 
proteinase-K digestion studies, that show differing pathological behavior in in vitro 
models for PD through differing recruitment of exogenous α-syn and tau aggregates, a 
significant component of Lewy bodies7.  This example highlights that the polymorphism 
in α-syn fibrils has potentially large impacts on the disease pathology and progression. 
Further studies by others showed that different fibril structures have significantly 
different acute toxicity levels in cell cultures, further supporting that the structure of α-
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syn fibrils has direct impact on PD8. With this ever-growing link between fibril structure 
and pathology, there is a need for atomic-level structural information to determine what 
differentiates these different pathological α-syn fibril forms to further our understanding 
of PD and to develop novel approaches to diagnosing and treating PD. 
 Despite this interest in the atomic-resolution structures of α-syn fibrils, the 
structure proved to be quite elusive, and it was only through extensive, comprehensive 
solid-state NMR (SSNMR) studies presented in this work that provide the first atomic-
resolution structure of α-syn fibrils. As amyloid fibrils are neither soluble nor crystalline, 
they were not suitable for traditional solution-state NMR or X-ray crystallography 
studies. Instead, SSNMR has proven uniquely capable of studying amyloid fibrils at 
atomic-resolution. In the case of α-syn fibrils, early studies proposed low-resolution 
structural models, based on limited distance information, that were extensions of the 
simple β-turn structures first identified in amyloid-β fibril structures (Fig 1.2)9,10. 
However, the full-length atomic-resolution structure presented in this dissertation reveals 
the surprising complexity of the α-syn fibril fold and suggests that the complexity of the 
fibril fold may be an important feature in fibril stability.  This conformation allows not 
only for the formation of the cross-β hydrogen bonding patterns and subsequent 
hydrophobic collapse commonly shown in amyloid fibril structures, but also for the 
formation of a stabilizing salt-bridge and important side chain interactions that are crucial 
for maintaining the fibril structure and will likely be structural features observed in future 
structures of additional fibril polymorphs8,10-12. 
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1.3 Figures 
 
 
Figure 1.1 | Intrastriatal inoculation of synthetic mouse α-Syn PFFs seed the 
aggregation of endogenous mouse Syn in wt mice. Pathology in brains of 
C57BL6/C3H F1 mice following a single unilateral injection of mouse α-Syn PFFs into 
the dorsal striatum. (A–D) Accumulation of α-Syn in neuritic processes or as pale 
cytoplasmic inclusions in striatum (Str) and neocortex (Ctx), and olfactory mitral neurons 
(OB) ipsilateral to the injection at 30d. Black arrows highlight pathology revealed by 
immunostaining using anti-pSyn (A–C) or Syn506 (D). (E,F) LB-like inclusions in 
striatum and contralateral neocortex at 180d post-injection with PFFs. (G) CNS 
distribution of pSyn accumulations of mice that received a single inoculation of PFFs in 
the dorsal striatum (indicated by grey circles). Representative maps of LB/LN-like 
pathology (red dots and stipples, respectively) in the PFF-injected hemisphere are shown 
for mice sacrificed at 30d, 90d, or 180d post-injection. (H) α-Syn pathology in amygdala 
(Amyg), and (I) in frontal cortex (Fr). (J) pSyn staining in ipsilateral striatum 160d post-
injection with monomeric recombinant α-Syn. (K) Double-immunostaining for pSyn 
(red) and TH (green) in a PFF-injected animal sacrificed at 180d showing LB-like α-Syn 
pathology in ipsilateral SNpc. (L) High magnification revealing colocalization of pSyn 
inclusions to DA neurons (white arrows) and reduced TH immunoreactivity compared to 
unaffected DA neurons (white arrowheads). Images are representative of 3–7 animals 
examined per group (see Table S1). Scale bars: 10 µm (A–C, E–F, H–L); 25 µm (D). 
Figure and caption reproduced from Luk et al. Science. 2012 Nov 16; 338(6109): 949–
953 with permission. 
 
  
! 6!
 
Figure 1.2 | Possible structural models of α-synuclein fibrils. Red marks indicate the 
same residues on different strands. Dashed lines indicate additional possible turn or bend 
regions. A, parallel β-hairpins stacked in sheets. B, additional β-strands to account for 
fibril dimension (see text). C, same as in B, indicating possible parallelism in the sheet 
direction. D, yellow strands represent an incoming molecule during fibril propagation 
based on model C. Red lines symbolize hydrogen bonding between existing fibrils and 
the incoming molecule. E, one example of fibril structure in which all strands within a 
given sheet are arranged in parallel. To accommodate fibril dimensions, several bends or 
turns have to occur. F, likely mechanism of fibril growth and propagation for model 
shown in E. Incoming molecule is shown in yellow. Hydrogen bonds are shown in red. 
Figure and caption reproduced from Der-Sarkissian, J. Biol. Chem., 278:39 37530-37535 
2003 with permission. 
 
1.4 References 
 
1 Spillantini, M. G., Schmidt, M. L., Lee, V. M. Y., Trojanowski, J. Q., Jakes, R. & 
Goedert, M. -Synuclein in Lewy bodies. Nature 388, 839-840, (1997). 
2 Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., 
Stieber, A., Meaney, D. F., Trojanowski, J. Q. & Lee, V. M. Exogenous -
synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and 
neuron death. Neuron 72, 57-71, (2011). 
3 Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Y. Addition of exogenous -
synuclein preformed fibrils to primary neuronal cultures to seed recruitment of 
endogenous -synuclein to Lewy body and Lewy neurite‚Äìlike aggregates. Nat. 
Protocols 9, 2135-2146, (2014). 
4 Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., 
Giugliano, M., Van den Haute, C., Melki, R. & Baekelandt, V. alpha-Synuclein 
strains cause distinct synucleinopathies after local and systemic administration. 
Nature 522, 340-+, (2015). 
5 Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O'Brien, P., Trojanowski, J. Q. & 
Lee, V. M. Pathological  -synuclein transmission initiates Parkinson-like 
neurodegeneration in nontransgenic mice. Science 338, 949-953, (2012). 
6 Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., 
Trojanowski, J. Q. & Lee, V. M. Exogenous -synuclein fibrils seed the 
formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. 
Acad. Sci. U.S.A. 106, 20051-20056, (2009). 
! 7!
7 Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. 
M., Kwong, L. K., Xu, Y., Trojanowski, J. Q. & Lee, V. M. Distinct -synuclein 
strains differentially promote tau inclusions in neurons. Cell 154, 103-117, 
(2013). 
8 Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., 
Madiona, K., Olieric, V., Bockmann, A., Meier, B. H. & Melki, R. Structural and 
functional characterization of two -synuclein strains. Nature Commun. 4, 2575, 
(2013). 
9 Der-Sarkissian, A., Jao, C. C., Chen, J. & Langen, R. Structural organization of 
-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278, 
37530-37535, (2003). 
10 Vilar, M., Chou, H. T., Luhrs, T., Maji, S. K., Riek-Loher, D., Verel, R., 
Manning, G., Stahlberg, H. & Riek, R. The fold of -synuclein fibrils. Proc. 
Natl. Acad. Sci. U.S.A. 105, 8637-8642, (2008). 
11 Gath, J., Habenstein, B., Bousset, L., Melki, R., Meier, B. H. & Bockmann, A. 
Solid-state NMR sequential assignments of -synuclein. Biomol. NMR. Assigm. 
6, 51-55, (2012). 
12 Gath, J., Bousset, L., Habenstein, B., Melki, R., Bckmann, A. & Meier, B. H. 
Unlike Twins: An NMR Comparison of Two -Synuclein Polymorphs Featuring 
Different Toxicity. PLoS One 9, e90659, (2014). 
! 8!
 
CHAPTER 2: 
STRUCTURE DETERMINATION BY SOLID-STATE NMR 
SPECTROSCOPY 
 
2.1 Abstract 
Solid-state NMR spectroscopy has established itself as an invaluable tool for 
structural studies of systems that had long been particularly challenging to investigate via 
traditional structure determination methodologies, including membrane proteins, amyloid 
fibrils, and large aggregates. While the overall strategies of solving structures via 
SSNMR closely mimic those used in solution NMR, approaches in SSNMR usually rely 
upon 13C sites throughout the protein to complete chemical shift assignments, secondary 
structure determination, and long-range distance restraint measurements as opposed to 1H 
in solution-state NMR spectroscopy. Here, we review the general process by which 
structures are solved via SSNMR spectroscopy. 
 
2.2 Introduction 
The first atomic-resolution structures of both a peptide1 and a protein2 via magic-
angle spinning solid-state NMR spectroscopy (SSNMR) were reported in 2002. In little 
more than a decade from these first landmark studies, SSNMR has advanced and evolved 
into an invaluable biophysical tool for studying the structures and dynamics of previously 
inaccessible protein systems ranging from membrane proteins to amyloid fibrils3-7.  With 
the further development of novel pulse sequences8, instrumentation9, and computational 
analysis10, SSNMR spectroscopy is increasingly able to study systems of broad interest 
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that were previously intractable via NMR due to low sensitivity and/or resolution. 
SSNMR spectroscopy methods have evolved into a somewhat standard protocol that 
mirrors the solution NMR structure determination process of obtaining chemical shifts, 
measuring distances, and performing structure calculations, that in the case of small 
globular proteins is extremely reliable and robust.  
 
2.3 Chemical Shift Assignments in SSNMR 
 The first stages of nearly any biomolecular study via NMR spectroscopy requires 
determining the correspondence of the observed signals to the atoms in the protein of 
interest. This process of assigning the chemical shifts of the protein relies upon the use of 
multidimensional experiments wherein atom connectivity is encoded within the 
experimental data. In solid-state NMR, one of the simplest examples of such a spectrum 
is a 15N-13Cα 2D correlation spectrum11, where magnetization is transferred through a 
heteronuclear transfer sequence such as cross polarization (CP), in which observed 
signals correspond to a pair of directly bonded backbone amide 15N and its corresponding 
Cα. Correspondingly, by collecting a 15N-13C’ spectrum, which identifies pairs of directly 
bonded backbone amide 15N and the backbone carbonyl 13C’ of the preceding residue, it 
is clear to see how one could connect a residue with the preceding residue through a 
shared 15N frequency. In order to expand this concept into experiments that connect the 
Cα and C’ frequencies through the shared 15N frequency, a series of standard 3D 
experiments, the 15N-13Cα-13C(x)11, 15N-13C’-13C(x)11, and 13Ca-15N-13C’12 experiments 
(Fig. 2.1) have been developed to establish the full backbone connectivity of a protein 
and to perform a backbone walk procedure to assign all of the signals in a protein. 
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 One of the key steps for determining the structure of a protein is obtaining the 
secondary structure of the protein. While the precise backbone torsion angles of the 
protein can be measured via SSNMR techniques such as vector angle measurements 
(VEANs)13, the 13C chemical shift is an extremely sensitive reporter on the local structure 
of the particular carbon, and it has been shown through empirical observation and 
quantum mechanical calculation that the precise secondary chemical shift of 13C atoms 
reports directly on the secondary structure14. Empirical databases of these relationships 
between the 13C secondary shifts, most famously the TALOS program from the group of 
Dr. Ad Bax, has proven to be an extremely reliable predictor of the secondary structure of 
protein using solely the assigned chemical shifts (Fig. 2.2)14,15. This process results in 
detailed secondary structure information immediately upon completion of chemical shift 
assignments, providing structural information prior to the measurement of long-range 
correlations. 
 
2.4 Measurement of Long-Range Distance Restraints 
 In order to obtain structures of proteins from NMR spectroscopy, one needs to 
measure restraints between different regions of the protein that are not close in primary 
sequence. In solution NMR, these distances are measured through the Nuclear 
Overhauser Effect (NOE), whereby polarization is transferred between to nuclear spins 
that are close in space through cross-relaxation. In MAS SSNMR spectroscopy, a wealth 
of literature is focused on the controlled recoupling of the dipolar coupling that is 
averaged out by magic-angle spinning. As the dipolar coupling is proportional to r-3, 
recoupling techniques that result in the transfer of magnetization through these dipolar 
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couplings are based almost entirely upon the distance between the two atoms. There are 
many forms of these heteronucleur (including famously REDOR16 and TEDOR17) and 
homonuclear recoupling (including SPCn 18 and DARR19) sequences that are capable of 
selectively re-introducing the dipolar coupling to obtain distance data in proteins. For 
example, a 13C-13C DARR correlation spectrum of α-syn fibrils (Fig. 2.3) shows a series 
of correlation between not only near neighbors in primary sequence, but also from signals 
that are from distant regions of the protein sequence, but are close in space. By obtaining 
a large number of these distance restraints (~15 restraints per residue for structures of 
exceptional quality), the conformational space of the protein consistent with the observed 
distances becomes increasingly limited. 
 In the case of large or highly degenerate proteins, the measurement of long 
distance restraints is often hampered by large line widths (on the order of 1 ppm 13C) and 
short T2s that further decrease spectral resolution. A powerful technique used in NMR 
structural studies is the use of sparse isotopically labeling during the preparation of the 
protein sample. One of the most common approaches is through the use of 1,3-13C and 2-
13C labeled glycerol as the carbon source during protein expression2. The resulting 
protein adopts a “checkerboard” labeling scheme where adjacent carbon atoms are rarely 
simultaneously labeled (Fig 2.4). This isotopic dilution not only reduces the total number 
of signals in the spectrum, but by removing adjacent carbons, homonuclear J-couplings  
which in SSNMR can contribute ~80 Hz to the 13Cα line width are reduced. The 
reduction of J-couplings and increased transverse relaxation time (T2) result in 13C line 
widths in glycerol-labeled samples of <=0.2 ppm and greatly increased sensitivity. 
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2.5 Calculation of high-resolution structures  
 Once a large number of restraints have been assigned in SSNMR spectra, these 
restraints need to be converted to distance restraints to be used in simulated annealing 
distance geometry optimization structure calculations. Because the recoupling sequence 
used to transfer magnetization relies upon the dipolar coupling, the intensity of the peak 
corresponds, at least qualitatively, to the distances between the two atoms. For instance, 
in the strip from a 13C-13C DARR spectrum in Figure 2.5, the V48 Cβ shows the strongest 
crosspeak to the V48 Cα residue, to which it is directly bonded. Conversely, the Cα of 
residues G47 and V49 are significantly farther in distance, resulting in much lower signal 
intensity. In the case of DARR, these cross peak intensities are only semi-quantitatively 
correlated to the distance between the two atoms as additional effects, such as spin 
diffusion and conformational dynamics can alter the signal intensity. Nevertheless, we 
can interpret these signals in terms of relative distances by using known protein structural 
features. For instance, two Cα in adjacent residues are almost always ~3.8 Å apart in 
space due to the limited conformational distances, while Cα residues of i+2 residues are 
~7.2 Å as shown in Figure 2.6. By finding signals that correlate to known distances in the 
protein, we can put semi-quantitative bounds on the distance restraints based on the 
relative signal intensities13,20. 
 These distance restraints are then used in simulated annealing distance geometry 
optimization software, such as XPLOR-NIH21, which combines database-based energy 
potentials with experimental distances and dihedral angles measured in sections 2.4 and 
2.3 to run short time-frame molecular dynamics trajectories over a slowly decreasing 
temperature that allows the protein structure to search a large conformational space to 
! 13!
minimize to overall energy and reach a convergent fold where all of the distance 
restraints are satisfied simultaneously with known protein structural limitations, such as 
torsion angles in Ramachandran space, improper angle, bond angles and distances, and 
Van der Waal’s contacts. A highly refined structure is the result of a combination of 
hundreds of distance restraints, empirically and experimentally measured dihedral angles, 
and quantitative distance measurements through more precise recoupling techniques, 
such as TEDOR. 
2.6 Figures 
 
 
Figure 2.1 | Polarization transfer pathways for three of the common SSNMR 
experiments used for assigning chemical shifts. By matching frequencies between the 
different spectra, using the 15N signal as a reference shift, it is possible to correlate 
chemical shifts between the ith residue and the i±1 residue.  
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Figure 2.2 | Secondary structure of α-syn fibrils determined by TALOS-N15. By 
using an empirical data base of known protein structures, TALOS-N is able to predict the 
backbone dihedral angles using only the assigned chemical shifts. 
 
 
 
 
Figure 2.3 | 13C-13C correlation spectrum of α-syn fibrils with 500 ms DARR mixing 
showing long range correlations. Three different spin systems, A78CA, G47CA, and 
G93CA all show long-range correlations to residues far apart in primary sequence. The 
cross peaks between A78 and G47 are cross validated through each spin system’s shared 
resonances.  
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Figure 2.4 | 1,3-13C- (Blue) and 2-13C-Glycerol (Red) labeling pattern for each amino 
acid type. The resulting checkerboard-like pattern from glycerol labeling results in 
narrow linewidths through the removal of most scalar couplings and allows for easier 
detection of long-range correlations in SSNMR spectra. This figure is used with 
permission from Protein-NMR: A Practical Guide. 
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Figure 2.5 | V48CB strip from a 13C-13C correlation spectrum of α-syn fibrils with 
500 ms DARR mixing. The relative intensities of the crosspeaks in this strip give 
qualitative information about the relative distance between the atoms – the weaker the 
signal, the further apart the two residues are. In this case, A78Cα is nearly as close the 
V48Cβ as the i-1 G47Cα. 
 
 
 
 
 
 
 
Figure 2.6 | Schematic of a protein backbone with common conserved distances. 
Using these known distances it is possible to use the long-range correlations from spectra, 
such as Fig. 2.5 to generate semi-quantitative long-range correlations for use in structure 
calculations. 
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CHAPTER 3: 
STRUCTURAL FEATURES OF AMYLOID FIBRILS 
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3.2 Abstract 
Amyloid fibrils have been implicated across a wide spectrum of 
neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and prion diseases. 
These unique biopolymers have many structural features that distinguish themselves from 
classic globular and membrane proteins that present challenges in traditional structure 
determination methodologies.  Currently there are structural models of several amyloids, 
including the fungal prion Het-S and the Alzheimer’s implicated amyloid-β. Significant 
advances in magic-angle spinning (MAS) solid-state NMR (SSNMR) spectroscopy have 
made these challenges tractable, but still require tailored experiments and samples to 
address these concerns. Structural features that define amyloid fibrils, the challenges they 
represent and experimental and computational approaches to elucidate these features, are 
reviewed.  
3.3 Introduction 
Amyloid fibrils are a class of fibrous, insoluble protein aggregates that have been 
implicated across a wide spectrum of diseases, including Alzheimer’s (AD)1, Parkinson’s 
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(PD)2,3, Huntington’s4, and prion diseases such as bovine spongiform encephalopathy, 
chronic wasting disease, Scrapie, Kuru, and Cruetzfeld-Jakob5. AD and PD, in particular, 
are the only diseases in the top 15 causes of death in America that cannot be prevented, 
cured, or slowed and can typically only be diagnosed based on patient symptoms. As 
these diseases become more prevalent in our aging society, mechanistic and structural 
insights into the underlying pathology will become crucial for developing new 
preventative and curative interventions. One key feature these neurodegenerative diseases 
share is that their associated protein aggregates have a misfolded amyloid β-sheet 
structure that has been hypothesized to be important for their pathogenicity and for their 
proliferation via a poorly understood prion-like mechanism6.  
These insoluble aggregates have proven difficult to study structurally, and by their 
insoluble and fibrous nature, are not conducive to standard structure determination 
methodologies such as X-ray diffraction or solution-state NMR. It is only recent 
advances in solid-state NMR (SSNMR) spectroscopy that have begun to provide atomic-
level structural information of these protein aggregates7. These SSNMR studies have 
shown that conformational changes in these aggregates correlate directly with changes in 
the pathology of the disease8,9. In the case of AD, SSNMR studies of the amyloid-β 
fibrils isolated from patient brains have identified two separate structural conformations 
that led to different clinical progressions of the disease8. Similarly, recent studies of the 
PD implicated α-synuclein (α-syn) fibrils have shown that different structural 
conformations of the fibrils have significantly different in vitro toxicities and progression 
in primary neuronal cell culture9. With this growing link between the structure of the 
amyloid fibril and the disease pathology, it is evident that increased structural knowledge 
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of the amyloid fibrils may provide key details into the mechanism of toxicity and 
proliferation, as well as serve as a basis for structure-specific biomarkers and treatments 
to address these diseases. Here we address the underlying structural details of amyloid 
fibrils that are crucial to determine in order to obtain atomic-resolution structures and 
experimental and computational approaches to elucidate these details. 
 
3.4 Amyloid Fibril Structural Features 
3.4.1 The cross-β amyloid structure and protomer architecture 
 Some of the earliest structural studies of amyloid fibrils were through the 
application of X-ray fiber diffraction, which established the presence of the cross-β 
pattern that has become a structural hallmark of amyloid fibrils10. This pattern (Fig. 3.1) 
establishes the presence of β-sheets whose hydrogen bonding axis is parallel to the fibril 
axis, resulting in the β-sheets running perpendicular, or across, the fibril axis in either a 
parallel (as shown in Figure 3.1), or anti-parallel β-sheet arrangement. Interestingly, all 
amyloid fibrils that have atomic-resolution structures that have been deposited in the 
RCSB Protein Data Bank (PDB)8,11-16 (with the exception of one structural model of 
amyloid-β17 and for calcitonin18) have a parallel in-registry cross-β arrangement, despite 
the long-standing belief in structural biology that anti-parallel β-sheets produce the 
highest inter-strand stability. This cross-β pattern gives rise to the long, unbranched, 
fibrils that were subsequently observed with electron microscopy, such as in Comellas et 
al.19. Due to this conserved structural feature, amyloids have long been commonly 
detected through biological assays including as the binding of Congo red or Thioflavin T. 
However, these techniques are not sufficient to determine what structural properties drive 
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the differences in structures and pathology in amyloid fibrils, and atomic-resolution 
details such as structural interactions, solvent accessibility, and conformational dynamics 
are key for furthering our understanding of amyloids and their related diseases.  
 Due to the hydrogen-bonding pattern from the cross-β arrangement, the number 
of possible architectures for a single protomer within the fibril is limited to one of two 
classes of architectures; the β-solenoid and β-serpentine architectures (Fig. 3.2). The β-
solenoid architecture is defined by a coiling of a single protomer, leading to more than 
one β-sheet spacing for each protomer unit along the fibril axis. This arrangement leads 
to a combination of β-sheet hydrogen bonding partners within a single protomer as well 
as the i+1 and i-1 protomers. In the case of a β-serpentine arrangement, however, all β-
sheet hydrogen partners are between i+1 and i-1 protomers, leading to a single protomer 
per spacing in the fibril. Both arrangements have been observed in in vitro amyloid 
structures (the fungal prion Het-S20 exhibits a β-solenoid while amyloid-β exhibits a β-
serpentine13) and distinguishing between these two arrangements is one of the key first 
steps in determining the structure of an amyloid fibril, as the interpretation of long-range 
restraints obtained from SSNMR data is simplified with this knowledge. 
3.4.2 Polymorphism and Stagger 
A long-standing tenant of structural biology (the Anfinsen hypothesis21) states 
that the sequence of a protein uniquely defines its 3D structure. This tenant has proved to 
be generally true for globular proteins and is useful in understanding and expanding our 
knowledge of structural biology and structure-function relationship through techniques 
such as homology modeling.  However, in the case of amyloid fibrils, there are 
significant exceptions to the Anfinsen hypothesis, as demonstrated by several recent 
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structures of polymorphs of amyloid-β.  In particular, there have been at least 6 structures 
of amyloid-β deposited to the PDB8,11,13,22,23, each with different core structures, or 
protofibrillar interactions (Fig. 3.3). The earliest structural model of amyloid-β13 (Fig 
3.3a) consisted of a basic β-hairpin-like turn in a single protomer with the parallel in-
register arrangement from above. This structure established many of the key structural 
interactions that drive the unusual stability of amyloid fibrils. In particular, it confirmed 
the long-standing hypothesis that hydrophobic interactions within the core were 
responsible for much of this stability. However, Petkova et al.13 also observed a salt-
bridge between residues D23 and K28, which was one of the first instances where 
charge-charge interactions were shown to be important in the fibril structure. Additional 
work by the Tycko lab subsequently identified structures with a similar β-hairpin-like 
structure, but where interfibrillar contacts formed dimer and trimer-like protomer 
interfaces at each spacing along the fibril core (Fig. 3.3a and 3.3b)24. These structures 
hinted at the growing complexity of amyloid fibril structures. Over the past 5 years, 
additional structures of different forms of amyloid-β have been identified in the literature 
from the groups of Ishii22, Meier11, and Tycko8 that show that even in the 40 residue-long 
amyloid-β fibrils, significant complexity in the protomer fold is correlated with fibrils 
that exhibit pathological behavior in vitro and in vivo, and that these different structures 
exhibit different pathologies, showing the variety of structures that are obtained from a 
single protein sequence. 
In the case where the protomer architecture is a β-serpentine arrangement and the 
protomer fold is known, there is still an ambiguity in the intermolecular interactions 
between protomers in the fibril. As two protomers in the fibril are separated only by the 
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backbone hydrogen bonds, the sidechains from the i+1 or i-1 (or in some cases i+2 and i-
2) protomers are in close enough proximity where the sidechains of the ith residue may 
fold with the sidechains of the i+1 or i-1 protomer24. This phenomenon is known as 
stagger, where the backbone of the protomer is skewed relative to the fibril axis resulting 
in intermolecular interactions not only through hydrogen bonds, but also with the 
sidechains. This behavior is particularly challenging to determine experimentally, and has 
been primarily discussed by the Tycko lab24, where they established that in the case of 
their amyloid-β structure, there is a favoring of a i+2 stagger which they believe allows 
for a better sidechain packing within the hydrophobic core. Subsequent structure of 
amyloid fibrils have neglected to further examine to effects of stagger despite the 
potentially important impact it has on fibril structure. In order to determine the structure 
of an amyloid fibril, it is necessary to not only measure long-range distance restraints, 
which help to define the structural complexity, but also to determine the cross-β pattern, 
the protomer architecture, and the extent of stagger, all of which require separate 
approaches to determine. 
 
3.5 Experimental Approaches to Determining Amyloid Fibril Structures 
3.5.1 Isotope Labeling Schemes for SSNMR 
NMR spectroscopy of biomolecules typically requires the isotope labeling of 
some combination of NMR active nuclei that are at low concentration in natural 
abundance, such as 15N and 13C. Most modern NMR sample preparations follow a 
protocol where the protein is over expressed in E. coli in a minimal media where the only 
carbon or nitrogen source available is 13C glucose/glycerol and 15N ammonium chloride. 
! 25!
Protein samples that are prepared in this manner typically have greater than 98% isotope 
incorporation. However, in the case of amyloids, the significant intermolecular 
interactions, including the cross-β registry, the monomer architecture, and the stagger, 
cannot be distinguished through uniformly, fully labeled samples. In order to separate 
these interactions, we can apply mixed or dilute isotope labeling schemes (Fig. 3.5), 
where only a portion of the sample is labeled with some combination of 13C and/or 15N, 
to allow for the unambiguous observation of strictly intermolecular or intramolecular 
interactions.  
A mixed isotopically labeled sample usually consists of 50% of the protein being 
labeled with 15N, with natural abundance carbon, while the remaining 50% of the protein 
is labeled with 13C, with natural abundance nitrogen (Fig. 3.5b). This technique has been 
applied previously in SSNMR to determine the crystalline or intermolecular contacts in 
protein samples25. In these prior reports, heteronuclear distance techniques, such as 
REDOR, TEDOR, and NHHC methods were applied to obtain site-specific distance 
restraints to define the molecular interface between proteins. In the case of amyloid 
fibrils, this is particularly beneficial for determining both the cross-β registry and the 
protomer architecture. In the case of a parallel in-register cross-β pattern, we would 
expect to see NMR crosspeaks between the 15N and 13C of the same or near neighbor 
residues in primary sequence. If we were to see a 15N signal corresponding to an N-
terminal residue interacting with a more C-terminal 13C signal, that would be indicative 
of an anti-parallel arrangement. Alternatively, for the case of determining the protomer 
architecture, we would predict that a β-serpentine architecture would show a 15N-13C 
correlation for a majority of the residues in the protomer, whereas a β-solenoid 
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arrangement would be more likely to lack signals for those residues that exhibit 
intramolecular β-sheet hydrogen bonds. In the case of a parallel in-register β-serpentine 
arrangement, we would expect to see a 15N-13C spectrum that shows correlations for each 
residue to itself throughout the entire protomer, such as is shown in Figure 3.6 for α-
synuclein. 
In order to determine the displacement of the β-strands along the fibril axis and 
the resulting stagger, dilute SSNMR samples, where only ~25% of the protein in the 
sample is isotopically labeled with 13C and 15N, allow us to determine which interactions 
are from primarily intramolecular contacts. While this labeling scheme comes at the cost 
of losing 75% of the signal intensity from the natural abundance material, the information 
content of the resolved long-range correlation give insights into the regions of the 
protomer that are nearly planar. Because all observed signals will now be almost entirely 
from intramolecular contributions, in the case of i±1 stagger, the backbone has moved 
~4.8 Å from a planar configuration, giving a signal loss of more than 65%. In most cases, 
combined with the signal loss from isotope dilution, this will make the long-range 
restraints that are due to stagger fall below the signal to noise threshold, and the 
remaining long-range correlations are assumed to be from intramolecular, in-plane 
interactions. These restraints are important for driving the structural determination 
process, and limiting the possible conformations that are possible.  
3.5.2 Computational Considerations for Amyloid Fibrils 
 Traditional NMR structure determination methodologies rely upon the 
combination of long-range distance restraints measured in multidimensional NMR 
spectra with a simulated annealing distance geometry optimization algorithm, such as in 
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the XPLOR-NIH26 software package. For a globular protein, this approach takes an 
extended chain protein and runs short molecular dynamics trajectories using naïve 
potential that are formed from databases of known protein structural information (such as 
Ramachandran space, bond lengths, bond angles, improper angles, etc) combined with 
experimental constraints while slowly lowering the kinetic energy of the system while 
ramping the potentials, the simulated annealing process attempts to minimize all of the 
potentials into a global minimum (Fig. 3.6). In the case of amyloid fibrils, the strong 
intermolecular interactions present a problem in the standard approach – a single 
monomeric unit cannot be used, as the backbone hydrogen-bonding partners are 
intermolecular, but each protomer has the same overall fold. To alleviate this problem, 
we run XPLOR-NIH calculation with an explicit non-crystallographic symmetry 
potential energy surface that relates each protomer through a translational symmetry (Fig. 
3.7). The potential forces each protomer to adopt the same fold within a subunit, but 
allows for the formation of the hydrogen bonding partners along the backbone. This 
approach allows for simultaneous calculation of a number of protomers (typically 3-10) 
to obtain a structure that correctly recreates the hydrophobic collapse of the core. 
 As discussed in section 3.4.2, the protomer may adopt a stagger within the fibril. 
While this issue can be alleviated through the measurement of long-range distances in 
dilute samples, in larger amyloid fibrils, such as α-synuclein, the signal-to-noise ratio of 
the long-range restraints in diluted samples is low enough where there are unlikely to be 
enough signals of high enough intensity to obtain a convergent structure. To alleviate this 
issue, we can detect long-range restraints on fully isotopically labeled samples (Fig. 
3.5a). While these restraints are not unambiguously intermolecular, we can include them 
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in the structure calculation as ambiguously inter- or intramolecular, and when combined 
with the limited unambiguously intramolecular restraints from the dilute sample, are 
enough to define the fold and overall amount of stagger in the protein. This approach was 
crucial for reaching the converged α-synuclein structure discussed in Chapter 5. 
 
3.6 The Particular Challenges of α-Synuclein 
 While α-syn fibrils share the same defining features of other amyloid fibrils, it 
presents unique challenges that have made the structure elusive when compared to some 
other amyloid fibrils such as Het-S and amyloid-β (Fig. 3.9). In particular, the molecular 
weight of α-syn is 14.4 kDa, almost twice that of the largest fibril solved to date, Het-S 
(Fig. 3.9b)20. Further complicating structural analysis, the structured core of the fibril has 
an unusually degenerate amino acid sequence, with a disproportionately high number of 
valines, glycines, alanines, and threonines (Fig. 3.9b). In terms of experimental data, this 
leads to a high degree of spectral degeneracy, which makes resolving individual spins 
challenging and requires additional labeling strategies, including 1,3-13C- and 2-13C- 
glycerol sources27, which due to a subsequent sparse labeling pattern as discussed in 
Chapter 2, leads to narrower lines through a removal of homonuclear 13C scalar 
couplings, resulting in linewidths of ~0.2 ppm. Additional conformational dynamics 
within the core (Fig. 3.9c), with regions such as residue 30-45 and 54-65 exhibiting lower 
signal-to-noise peaks, makes structural characterization of these regions particularly 
challenging. In order to obtain the atomic-resolution structure of α-syn fibrils, it takes a 
combination of the techniques discussed in this chapter with large quantity, carefully 
prepared SSNMR samples, as discussed in Chapter 4, with long signal averaged 2D and 
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3D multidimensional spectra on a stable, finely-tuned spectrometer. Using this approach, 
we were able to combine traditional SSNMR methodologies with these refined 
approaches for amyloids to solve the structure of α-syn fibrils, as discussed in Chapter 5. 
3.7 Figures 
 
Figure 3.1 | Amyloid Fibril Cross-β  Architecture. Amyloid fibrils are defined typically 
by a parallel in register β-sheet hydrogen bonding with an antiparallel arrangement within 
a single protomer. 
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Figure 3.2 | Amyloid Fibril Protomer Architecture. Amyloid fibrils are defined 
typically by a parallel in register β-sheet hydrogen bonding with an antiparallel 
arrangement within a single protomer. 
 
 
 
Figure 3.3 | Amyloid fibrils are polymorphic, and can have very complex core 
structures. Amyloid fibrils are defined typically by a parallel in register β-sheet 
hydrogen bonding with an antiparallel arrangement within a single protomer. 
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Figure 3.4 | Stagger between protomers adds complexity to the structure that is hard 
to experimentally determine. Amyloid fibrils are defined typically by a parallel in 
register β-sheet hydrogen bonding with an antiparallel arrangement within a single 
protomer. 
 
 
 
Figure 3.5 | Isotope labeling patterns that are crucial for determining the 
architecture and fold of the protomer. Amyloid fibrils are defined typically by a 
parallel in register β-sheet hydrogen bonding with an antiparallel arrangement within a 
single protomer. 
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Figure 3.6 | Intermolecular Registry of α-Synuclein fibrils. Amyloid fibrils are 
defined typically by a parallel in register β-sheet hydrogen bonding with an antiparallel 
arrangement within a single protomer.  
 
 
 
 
Figure 3.7 | Standard process for a globular protein structure calculation. Amyloid 
fibrils are defined typically by a parallel in register β-sheet hydrogen bonding with an 
antiparallel arrangement within a single protomer. 
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Figure 3.8 | Noncrystallographic translational symmetry. Amyloid fibrils are defined 
typically by a parallel in register β-sheet hydrogen bonding with an antiparallel 
arrangement within a single protomer. 
 
 
 
Figure 3.9 | α-Synuclein has a larger core and more amino-acid degeneracy than 
any amyloid fibril whose structure has been solved to date. Amyloid fibrils are 
defined typically by a parallel in register β-sheet hydrogen bonding with an antiparallel 
arrangement within a single protomer.  Reproduced with permission from Comellas et al. 
Ann. Rev. Biophys. 42: 515-536, 2013. 
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CHAPTER 4: 
PREPARATION OF AMYLOID FIBRILS FOR MAGIC-ANGLE 
SPINNING SOLID-STATE NMR SPECTROSCOPY 
4.1 Notes and Acknowledgements 
 This chapter is adapted with permission from Methods in Molecular Biology: 
Protein Amyloid Aggregation, Preparation of Amyloid Fibrils for Magic-Angle Spinning 
Solid-State NMR Spectroscopy, authors: Marcus D. Tuttle, Joseph M. Courtney, 
Alexander M. Barclay, and Chad M. Rienstra. This!work!was!supported!by!NIH!grants!R01<GM073770.! M.D.T.! and! A.M.B.! were! supported! by! NIH! Training! Grant! PHS! 5!T32! GM008276! and! J.M.C.! was! supported! by! a! National! Science! Foundation!Graduate!Research!Fellowship. 
4.2 Abstract 
Solid-state NMR spectroscopy (SSNMR) is established as an invaluable tool for 
the study of amyloid fibril structure with atomic-level detail. Optimization of the 
homogeneity and concentration of fibrils enhances the resolution and sensitivity of 
SSNMR spectra. Here, we present a fibrillization and fibril processing protocol, starting 
from purified monomeric α-synuclein, that enables the collection of high-resolution 
SSNMR spectra suitable for site-specific structural analysis. This protocol does not rely 
on any special features of α-synuclein and should be generalizable to any other amyloid 
protein. 
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4.3 Introduction 
Characterization of amyloid fibrils via magic angle spinning (MAS) solid-state 
NMR (SSNMR) spectroscopy has led to previously inaccessible insights into the 
structure of proteins including amyloid-β 1-3, Het-S 4,5, and α-synuclein 6-8. Obtaining 
high-resolution data through the proper production of fibrils from monomeric protein 
solution is paramount to the investigation of the structure, function, and pathology of 
amyloids. Many biophysical studies rely on assays performed directly on aliquots taken 
from the fibrillization mixture 9 or on sample production techniques with insufficient 
yields to perform NMR spectroscopy. However, in MAS SSNMR, spectra of the 
unrefined fibrillization mixture can exhibit broad spectral features arising from 
heterogeneities in the fibril size or polymorph, as well as background signal from residual, 
soluble monomer 10. The following protocol maximizes the fraction of protein 
incorporated into mature fibrils and describes a washing procedure to reduce ionic 
strength and remove remaining monomer and small protofibrillar aggregrates, greatly 
improving the homogeneity of the sample as well as the performance of the NMR 
instrument, thereby resulting in higher quality NMR data.  
The use of this procedure has consistently produced α-synuclein samples of homogenous 
morphology that give high resolution spectra (<0.5 ppm 13C linewidths in uniformly 
13C,15N labeled samples and <0.3 ppm 13C  linewidths for sparsely labeled samples 11,12) 
that facilitate the assignment of chemical shifts for the fibrillar cores of wild-type α-
synuclein and the early-onset related mutants: A30P, E46K, and A53T 11,13,14.  
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4.4 Materials 
All solutions are made with ultrapure water de-ionized to a resistivity of 18.2 
MOhm, filtered through a 0.22 µm filter, and stored at room temperature until use, unless 
otherwise noted. Reagents for buffers and solutions are analytical grade. Follow all 
applicable waste disposal regulations when disposing of waste materials. Although the 
safety of handling recombinant amyloid proteins has not been assessed in all cases, we 
recommend using appropriate personal protective equipment to avoid direct contact 
whenever possible 9. 
4.4.1 Size Exclusion Chromatography 
1. Purified α-synuclein monomer in solution 10,15. (see Note 1) 
2. Amicon stirred cell concentrator 200 mL, Model 8200, (Part Number part 5123) 
(Millipore) 
3. 3 kDa molecular weight cut-off filter for Amicon stirred cell concentrator 
4. Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-3 membrane, 3 kDa 
NMWL (Part Number UFC900308) (EMD Millipore) 
5. Eppendorf Centrifuge 5810R equipped with swinging bucket rotor A-4-62 
6. 0.22 µm syringe tip filter 
7. 3 L Size exclusion buffer: 100 mM sodium phosphate, 1 mM EDTA, 0.01% w/w 
NaN3, pH 7.4, stored at 4 °C, sterile filtered and degassed. 
8. 2 L Ultrapure water, stored at 4 °C, sterile filtered and degassed. 
9. GE Healthcare’s HiPrep 26/60 Sephacryl S-200 High Resolution gel filtration 
column, 320 mL column volume 
! 40!
10. GE Healthcare’s ÄKTAprime plus FPLC equipped with fraction collector, UV 
detector, and chart recorder or recording software. 
11. 50 fraction collection tubes of at least 5 mL each 
12. 5 mL sample loop 
4.4.2 Final Concentration 
1. Amicon stirred cell concentrator 200 mL, Model 8200, (Part Number part 5123) 
(EMD Millipore) 
2. 3 kDa molecular weight cut-off filter for Amicon stirred cell concentrator 
3. Pre-Fibrillization Dilution Buffer: 1mM EDTA, 0.01% NaN3 in H2O 
4. Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-3 membrane, 3 kDa 
NMWL (Part Number UFC900308) (EMD Millipore) 
5. Eppendorf Centrifuge 5810R equipped with swinging bucket rotor A-4-62 
4.4.3 Seeding and Fibrillization 
1. Fibrillization Buffer: 50 mM sodium phosphate, 1mM EDTA, 0.01% NaN3, pH 
7.4 
2. Beckman Coulter Tubes, with Snap-On Cap, Polypropylene, 1.5 mL, 11 x 38 mm, 
Natural.  (Part Number 357448) (see Note 2) 
3. 0.22 µm syringe tip filter 
4. Preformed α-synuclein fibrils (see Note 3) 
5. Parafilm 
6. New Brunswick Scientific Co., C-24 Classic Benchtop Incubator Shaker 
4.4.4 Fibril Harvest 
1. Hand-held pellet pestle grinder (Part Number Z359971-1EA) (Sigma-Aldrich) 
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2. Pellet pestle, autoclaved (Part Number Z359947) (Sigma-Aldrich) 
3. Beckman TL-100 tabletop ultracentrifuge 
4. An air manifold with nylon tubing 
4.4.5 Rotor Packing: 
1. Rotor Sleeve, 3.2 mm, 22 µL (Part Number MSPA005053) (Agilent 
Technologies) 
2. Packing Tool Kit, 3.2 mm, 22 µL (Part Number MSPA000272) (Agilent 
Technologies) 
3. 3.2 mm, 22 µL, Drive Cap, Torlon, CS (Part Number MP4140-001) (Revolution 
NMR) 
4. Half Top Cap, 3.2 mm, 22 µL (Part Number MP4603-001) (Revolution NMR) 
5. 2 Spacers, Custom Made, Kel-F, one 0.078” diameter, 0.073” length, one 0.078” 
diameter, 0.153” length. All measurements within +/- 0.001” tolerance 
6. Rubber discs, Custom Made, 0.078” diameter, 0.063” length 
7. Disposable aluminum dishes (Part Number Z154857-1PAK) (Sigma-Aldrich) 
4.5 Methods 
Carry out all procedures at room temperature unless otherwise specified. 
4.5.1 Size Exclusion Chromatography 
Size exclusion chromatography is performed in a cold box or cold room at 4ºC. 
1. Equilibrate the 26/60 Sephacryl S-200 High Resolution gel filtration column with 
at least 3 column volumes of size exclusion buffer using a flow rate of 0.5 
mL/min with the ÄKTAprime.  
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2. Using the Amicon stirred cell concentrator with a 3 kDa molecular weight cut-off 
filter, bring the total volume of purified α-synuclein in solution to ~5 mL. (see 
Note 4) 
3. Transfer the concentrate to an Amicon Ultra-15 centrifugal Filter Unit, Rinse the 
stirred cell membrane and concentrator with ~5 mL of size exclusion buffer and 
add the rinsate to the same centrifugal filter unit (see Note 5). 
4. Concentrate the sample down to ~5.5 mL by centrifugation in the swinging 
bucket rotor A-4-62 at 4000 r.p.m.. Spin time will vary with monomer 
concentration. 
5. Draw the concentrate into a 10 mL syringe and pass through a 0.22 µm filter into 
a sterile plastic tube. Draw the filtered solution into a second 10 mL syringe and 
tap out all bubbles just prior to injection into the FPLC sample loop.  
6. Run the sizing column at a flow rate of 1.3 mL/min after injecting the sample into 
the sample loop as follows: 0-5 mL, inject valve set to LOAD; 5.1-25 mL, inject 
valve set to INJECT; 25.1-980 mL, inject valve set to LOAD. 6.5 mL fractions 
are collected over 40.1 mL-320 mL.  
7. Combine Fractions containing the protein (see Notes 6 and 7) 
4.5.2 Final Concentration 
1. Add the combined fractions to the stirred cell concentrator with a 3 kDa cut-off 
membrane and add enough pre-fibrillization dilution buffer to double the total 
volume, bringing the phosphate buffer concentration to 50 mM (see Note 4) 
2. Take an A280 to determine the protein concentration. The target concentration for 
fibrillization is 15 mg/mL. 
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3. Concentrate the solution down until you have less than 15 mL remaining or you 
have reached 15 mg/mL concentration of the monomer. Transfer the concentrate 
to an Amicon Ultra-15 centrifugal Filter Unit, rinse the stirred cell membrane and 
concentrator with ~5 mL of size exclusion buffer and add the rinsate to the same 
centrifugal filter unit (see Note 5). 
4. Concentrate further with the Amicon centrifugal concentrator to a concentration 
slightly above 15 mg/mL as measured by A280 and add the solution to a 25 mL 
conical centrifuge tube. 
5. Use an appropriate volume of Fibrillization Buffer to rinse the Amicon 
concentrator such that, when added to the monomer solution, it reaches a final 
monomer concentration to 15 mg/mL. (see Note 8) 
4.5.3 Seeding and Fibrillization 
1. Measure the total volume of concentrated α-synuclein monomer. Gather enough 
Beckman Coulter ultracentrifuge tubes to divide the solution into 0.5 mL fractions 
in each tube. 
2. Using a syringe and long needle, collect the monomer solution into the syringe. 
3. Remove the needle and attach the 0.22 µm syringe tip filter. 
4. Divide the solution by 0.5 mL into separate microfuge tubes. If there is less than 
100 µL remaining split it between the other tubes, otherwise add it to a new tube.  
5. Combine the preformed fibrils and enough of the Fibrillization buffer to bring the 
concentration to ~15 mg/mL (see Note 9) 
6. Bath sonicate the preformed fibril mixture for 30 seconds or until the fibrils 
appear to be well dispersed. 
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7. Add 25 µL of the sonicated mixture to each microfuge tube to seed the fibril 
growth at a 5% seeding level. If a tube has a volume other than 0.5 mL adjust the 
volume of seed solution to compensate. 
8. Close and tightly parafilm each tube. Vortex each for 30 seconds. 
9. Add the fibrils to the Benchtop Incubator Shaker set to 37 °C at 200 r.p.m. 
10. Within 24-72 hours the solution should begin forming a gel and may become 
cloudy. 
11. Allow to fibrillize for 3 weeks. This time frame shows a convergence of SSNMR 
chemical shifts (Fig. 4.1) within the first week and a maximized fibril yield by the 
end of the 3-week incubation. 
4.5.4 Fibril Harvest 
1. Collect the microfuge tubes from the incubator and remove all parafilm. 
2. Ultracentrifuge at 4 °C and 55,000 rpm for 1-2 hours in a TLA-100.3 rotor with 
adapters for the microfuge tubes. Decant the supernatant and save for analysis. 
(see Note 10) 
3. Add 100 µL of sterile filtered ultrapure water to each tube and use the pellet 
pestle grinder to resuspend the fibrils.  
4. Combine three tubes into one and rinse out each empty microfuge tube with an 
additional 100 µL of sterile filtered ultrapure water and add to the combined 
suspension. 
5. Ultracentrifuge again at 4 °C and 55,000 rpm for 1-2 hours in a TLA-100.3 rotor 
with adapters for the microfuge tubes. Decant and save the supernatant. 
6. Repeat steps 3-5 for an additional wash. (see Note 11) 
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7. Arrange the air manifold to dry the fibrils over N2 (Fig. 4.2). Be sure to poke a 
hole in the caps of the microfuge tubes with a syringe needle for air release and to 
include the water bubbler to maintain a safe pressure. 
8. Turn on the nitrogen gas to a very low flow and a pressure of 1-2 p.s.i. 
9. Dry the fibrils under N2 for at least 2-3 hours and up to overnight until the mass 
stops changing. The resulting dry fibrils should look like a thin clear sheet of mica. 
Dry Fibrils can be stored at 4 °C until ready to pack into a SSNMR Rotor. 
4.5.5 SSNMR Rotor Packing 
1. Collect the Rotor Sleeve, drive cap, top cap, both Kel-F spacers, and rubber discs. 
Wash them thoroughly, first with water, then ethanol, and a second wash with 
water. Allow to dry. Record mass of all rotor components (see Note 12) 
2. Insert one of the rubber discs into the rotor sleeve. (see Note 13) 
3. Lightly start inserting the top cap into the same end of the rotor as the rubber disc 
using finger pressure. The drive tip should enter the sleeve ~3/4 of the way using 
finger pressure. 
4. Put the rotor into the collet chuck from the packing tool kit and attach the screw 
press assembly. Finish inserting the top cap into the sleeve using the screw press 
ensuring that there is no gap between the rotor sleeve and drive cap. (see Note 14) 
5. From the opposite end of the rotor, insert the shorter Kel-F spacer and push it to 
the opposite end so that it is pressed against the rubber disc. Re-record the mass of 
all rotor components. 
6. Mass the partially assembled rotor in a disposable aluminum weighboat to 
determine the starting mass. Slowly add dried fibrils to the rotor until you have 
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added up to ~12mg. Record the total mass of the protein added. (see Notes 15 
and 16) 
7. Rehydrate the dried fibrils by adding ultrapure water to 50% by weight of the total 
protein added in the previous step. This water is vital for obtaining high-
resolution spectra. (Fig. 4.3) Record the amount of water added. (see Note 17)  
8. Spin the rotor for 30 seconds in the swinging arm rotor at 5,000 r.p.m. to help 
distribute the water. This can be done by placing the rotor inside of a microfuge 
tube inside of a 50 mL conical centrifuge tube. 
9. Place the long Kel-F spacer into the top of the rotor, followed by the rubber disc 
and finally with the drive cap. (see Note 18) 
10. Similar to inserting the top cap, use the collet chuck and screw press to insert the 
drive cap completely. Add a mark to the top cap using a black sharpie for the 
tachometer. Record the final mass of the rotor. 
4.6 Notes 
1. We have stored purified α-synuclein monomer at ~0.7 mg/mL in 50 mM sodium 
phosphate, 1 mM EDTA, 0.01% NaN3, pH 7.4 at 4 °C for periods of several days 
with no observable adverse effects. We typically start a fibril prep with a total 
volume of 75-100 mLs, corresponding to approximately 50-70 mgs of pure 
protein. 
2. It is important that the microfuge tubes be ultracentrifuge compatible. 
3. Preformed fibrils can be prepared using this protocol without the addition of seeds 
during the fibrillization stage by spontaneous nucleation 
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4. Running ~10 mL of buffer through the stirred cell concentration apparatus prior to 
adding the protein solution will ensure that it was correctly assembled and not 
leaking, preventing the loss of material. 
5. We typically save the stirred cell membrane in submerged size exclusion buffer to 
later quantify protein loss due to adhesion to the membrane surface. The loss is 
usually minimal if the rinse is properly performed. 
6. The sizing column trace may have a large shoulder that runs at a larger size than 
the monomer peak (45 kDa, see Note 7). This can indicate the presence of an 
aggregate in the monomer solution that can lead to inconsistent fibrillization 
results. 
7. We and have observed that in the case of α-synuclein, the monomer elutes under 
these conditions at a volume corresponding to a 45 kDa globular protein. 
8. After reaching this point, if seeding (see Note 9), make all attempts to move to 
fibrillization as quickly as possible to prevent the possibility of undesired 
spontaneous aggregates forming in the solution. 
9. Seeding is optional. In our experience this protocol will produce consistent α-
synuclein fibrils from batch to batch regardless of whether preformed fibril seeds 
were added or not. We suggest seeding to see an increase in fibril yield and guard 
against any possible undesired-pathway aggregates forming. 
10. There should be a very clear gelatin-like pellet after ultracentriguation. 
Sometimes the pellet is hazy or has apparent layers, but these are removed during 
the washing steps. 
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11. The washing steps remove any remaining monomer and/or protofibrils from the 
fibrils and enhanced the quality of the data of the fibrils. 
12. It is possible that improperly sized parts can cause instabilities in rotor spinning. 
We find it beneficial to test the rotor packed with baking soda to ensure it spins 
properly prior to packing the NMR sample. 
13. If the rubber disc is not placed evenly into the rotor sleeve, it can introduce 
spinning instabilities.  
14. The screw press assembly applies a constant and symmetric force to the drive tip, 
which should ensure that you do not add torque that could cause the rotor to crack. 
15. It helps to crush the dried fibrils lightly with a small spatula prior to packing. 
16. The crushed fibrils can cling to surfaces through static electricity. We recommend 
using the aluminum weigh boats to circumvent the fibrils sticking. 
17. It can be beneficial to add the water in stages during the packing to ensure even 
distribution of the water. 
18. Sometimes water squeezes out of the rotor during this step, so adding 50% w/w 
water ensures you reach a minimum of ~36% hydration in the enclosed rotor. 
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4.7 Figures 
 
Figure 4.1 | Transition from α-helix to β-sheet evidenced by the changes in chemical 
shifts of α-synuclein incubated in the presence of phospholipid. Note that although the 
protocol described here does not include phospholipids, a similar time dependence of 
spectral quality has been observed for α-syn fibrillized following this protocol. Differing 
fibrillization times have been reported for amyloid fibrils of different proteins.  (A) 
Expanded regions of 13C−13C 2D spectra of α-synuclein incubated in the presence of 
phospholipid for 0, 1, 2, 3, 6, and 11 days. All contours were drawn at ∼6σ. Full 13C−13C 
2D spectra of samples incubated for (B) 0, (C) 1, and (D) 11 days. Expanded regions 
shown in part A are highlighted in gray. Reprinted with permission from G. Comellas, et 
al. J. Am. Chem. Soc. 134, 5090-5099 (2012). Copyright 2012 American Chemical 
Society. 
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Figure 4.2 | Diagram of the drying apparatus. An air manifold is attached to a N2 
cylinder and nylon tubing to dry the fibril sample. The water bubbler is a safety feature to 
keep the manifold from over pressurizing. The valve to the bubbler should never be shut 
off. 
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Figure 4.3 | Optimizing hydration of α-synuclein fibril samples for the solid-state 
NMR experiments (mass of water ÷ total mass). (a) 1H 1D spectra of U-13C,15N α-
synuclein fibrils at different hydration levels (dry, 16%, 26%, 36%, 44% and 50%) and 
(b) 13C–13C 2D spectra with 50-ms DARR mixing. All spectra were acquired under 
identical conditions at 600-MHz (1H frequency) and 13.3-kHz MAS rate. Dry fibrils 
correspond to fibrils dried by N2 gas until no changes in mass were observed, as 
previously described. Spectra marked in blue correspond to the optimal conditions 
selected for the multidimensional NMR experiments. Reprinted from Comellas,	 et	 al.,	Structured	regions	of	α-synuclein	fibrils	include	the	early-onset	Parkinson's	disease	mutation	sites.	J.	Mol.	Biol.	411,	881-895	(2011),	with	permission	from	Elsevier. 	
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CHAPTER 5: 
SOLID-STATE NMR STRUCTURE OF A PATHOGENIC FIBRIL OF FULL-
LENGTH, HUMAN α-SYNUCLEIN 
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This chapter is adapted from an article in preparation for submission, entitled 
Solid-State NMR Structure of a Pathogenic Fibril of Full-Length, Human α-Synuclein. 
The authors of this manuscript are Marcus D. Tuttle, Gemma Comellas, Andrew J. 
Niewkoop, Dustin J. Covell, Deborah A. Berthold, Kathryn D. Kloepper, Joseph M. 
Courtney, Jae K. Kim, Michele McDonald, Gerald Stubbs, Charles D. Schwieters, 
Viriginia M. Y. Lee, Julia M. George, and Chad M. Rienstra. The work was supported by 
the National Institutes of Health (R01-GM073770, P50 NS053488, P01 AG002132) and 
utilized equipment procured with support of S10RR025037 from the National Center for 
Research Resources. M.D.T. is a member of the NIH Molecular Biophysics Training 
Grant at the University of Illinois at Urbana-Champaign (PHS 5 T32 GM008276) and 
D.J.C. is supported by T32-AG000255. J.M.C. is supported by a National Science 
Foundation Graduate Research Fellowship. C.D.S. is supported by the Intramural 
Research Program of CIT at the National Institutes of Health. The authors thank Joseph 
Wall and Beth Lin for STEM MPL sample preparations and data collection. The 
Brookhaven National Laboratory STEM is a National Institute of Health supported 
Resource Center, NIH 5 P41 EB2181, with additional support provided by the 
Department of Energy, Office of Biological and Environmental Research. TEM images 
were carried out in the Frederick Seitz Materials Research Laboratory Central Facilities, 
 55 
University of Illinois, which are partially supported by the U.S. Department of Energy 
under grants DE-FG02-07ER46453 and DE-FG02-07ER46471. The Stanford 
Synchrotron Radiation Lightsource (SSRL) is a national user facility operated by 
Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic 
Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the 
DOE and NIH. The authors thank Amy Kendall of Vanderbilt University for providing 
TMV for the MPL STEM investigations of this study. I would also like to thank Dr. Ming 
Tang for helpful discussions. 
 
5.2 Abstract 
Misfolded α-synuclein (α-syn) amyloid fibrils are the principal components of Lewy 
bodies and neurites, hallmark lesions of Parkinson’s disease (PD). Here we present a 
high-resolution 3D structure of α-syn fibrils, in a form that induces robust pathology in 
primary neuronal culture, determined by magic-angle spinning solid-state NMR 
spectroscopy. From 68 multidimensional spectra collected from samples with six isotopic 
labeling patterns, over 7,500 cross peaks were assigned, including 210 unique long-range 
restraints that define a consensus structure. The fibril structure adopts a novel Greek-key 
topology within a β-serpentine arrangement containing parallel in-register β-sheets, 
complementary sidechain packing, an intermolecular salt bridge, intermolecular hydrogen 
bond interactions, and a hydrophobic core. These structural insights may facilitate an 
improved understanding of α-syn fibril nucleation, propagation, and interactions with 
small molecules in order to diagnose and treat PD. 
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5.3 Introduction 
Parkinson’s disease (PD) is pathologically characterized by Lewy bodies (LBs) 
and Lewy neurites (LNs)1, intracytoplasmic aggregates containing α-synuclein (α-syn) 
fibrils1. Exogenous α-syn fibrils seed LB- and LN-like inclusions in cell culture models2,3 
and neuron-to-neuron α-syn transmission propagates PD-like pathology4. Inoculation of 
preformed α-syn fibrils into wild type non-transgenic mice seeds aggregation of 
endogenous mouse α-syn and reproduces key features of the neurodegenerative cascade5. 
Additionally, recent mouse model studies have established that different α-syn fibril 
strains cause distinct synucleinopathies with differing toxicity profiles6.   
Although secondary structures have been examined for several α-syn fibril forms 
by solid-state NMR (SSNMR) spectroscopy7-10, thus far there is no reported high-
resolution three-dimensional structure. The α-syn monomer (14.5 kDa) is significantly 
larger than other amyloid proteins whose structures have been solved, such as Het-S (8.6 
kDa)11, β2-microglobulin (2.5 kDa)12, and amyloid-β (Aβ, 4 kDa)13-16. In addition to size, 
the highly repetitive secondary structure and residue type degeneracy in α-syn present 
major challenges for high-resolution structure determination. To address these 
challenges, we have performed a comprehensive structural study of an α-syn fibril form 
previously reported by our group7,17,18. Utilizing extensive sample preparation, data 
collection, and computational analysis efforts, we determined a single unique 
conformation in which the core residues are arranged in parallel, in-register β-sheets with 
a Greek-key topology.  The structure is validated with measurements of fibril width, 
intermolecular stacking and β-sheet spacing by electron microscopy and X-ray fiber 
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diffraction.  These structural insights establish the basis for an improved understanding of 
α-syn fibril nucleation, propagation, and interactions with small molecules of potential 
utility for the diagnosis and treatment of PD. 
 
5.4 Results 
5.4.1 α-Syn fibrils prepared in vitro are pathogenic to neuronal cells 
To determine if the α-syn fibrils used in this study for high-resolution 3D 
structural determination are pathophysiologically indistinguishable from those previously 
evaluated using cell-based models, we added fibrils to primary hippocampal neurons and 
showed the induction of insoluble, phosphorylated α-syn inclusions in a dose dependent 
manner2,3 as indicated by immunostaining with 81A, an antibody specific for 
phosphorylated Ser129  (Fig. 1a-b).  Furthermore, treatment at doses >250nM showed 
neuronal injury/death as determined by LDH release into the culture media (Fig 1c). This 
is consistent with our previously published data using other fibril preparations in primary 
culture and wild-type mice3,5. Thus, the α-syn fibrils used in this study act as pathological 
seeds capable of initiating a disease-like cascade. To ensure that LDH release was not 
from residual endotoxin present from the protein expression in e. coli, we measured that 
the endotoxin ranged between 0.0094-0.0452 EU/treatment respective to the pre-formed 
fibril concentrations used (0.0031-0.0151 EU/µg α-syn), which has been shown to be 
below the limit that causes LDH release in α-syn toxicity assays19. 
5.4.2 Long-range structural restraint of α-syn fibrils from solid-state NMR spectroscopy 
We then proceeded to prepare isotopically labeled α-syn fibril samples for magic-
angle spinning (MAS) SSNMR spectroscopy studies (Fig. 5.2).  Importantly, the fibril 
 58 
samples consistently reproduced the morphology observed in our prior reports7,17,18, 
enabling us to prepare several ~20 mg samples of identical form but with different 13C 
and 15N isotopic labeling patterns, customized in each case to enable collection of the 
crucial SSNMR data sets containing unique information (Table 5.1). We utilized the 
uniformly-13C, 15N-labeled α-syn fibrils to confirm and extend the resonance assignments 
using optimized 3D pulse sequences20. We then employed sparsely labeled α-syn fibril 
samples using 1,3-13C-glycerol or 2-13C-glycerol as the primary 13C sources21 in the 
growth medium, to enhance spectral resolution and sensitivity, which revealed many new 
long-range restraints in a series of 2D 13C-13C and 3D 15N-13C-13C measurements. We 
prepared an additional sample of U-13C,15N α-syn monomer diluted in natural abundance 
α-syn prior to fibrillation, facilitating SSNMR measurements that detect unambiguously 
intramolecular 13C-13C correlations22 (Fig. 5.3). This spectrum revealed long range 
correlations between A78-V48, A69-G93, F94-I88, and V82-A89. As these strictly 
intramolecular long-range restraints are spread throughout the core, this rules out 
structural models that exhibit a domain swap. Finally, we generated mixtures of 13C-
labeled α-syn monomer (from each of the glycerol sources) with 15N-labeled monomer, 
yielding isotopically mixed fibril samples that permitted the unambiguous detection of 
intermolecular restraints, via 3D 15N-13C TEDOR12 (Fig. 5.4). 
In total, we collected 52 2D and 16 3D SSNMR spectra (Table 5.2), exhibiting 
7,704 total assigned cross peaks, from which hundreds of long-range distance restraints 
were identified (Table 1). Most critically, the 3D 15N-13C-13C and 2D 13C-13C with 
samples B and C (Table 1) were collected at a series of DARR23 13C-13C mixing times 
(from 50 ms to 500 ms), enabling the identification of 180 unambiguous and 80 
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ambiguous long-range correlations (the ambiguous cross peaks each exhibited less than 6 
possible assignments). We also assigned 30 unambiguous and 5 ambiguous long-range 
15N-13C correlations in TEDOR experiments12,24 (Table 1). Taken together, many of the 
unambiguous correlations report on the key structural features of the folded protomer 
within the fibril (Fig. 5.5 a-f):  (A) residues G68 and A69 are packed closely to G93; (B) 
G47 and V48 are close to A78; (C) the side chains of I88, A91 and F94 exhibit a number 
of side chain-side chain correlations defining a hydrophobic pocket; and Q79 is 
positioned centrally in the core, with (D) backbone interactions to G47, V77 and V82, (E) 
a side chain closely approaching A89 and A90, and (F) a side chain amide 15N that tightly 
packs against methyl groups of V77, V82 and A89. Notably, many of these diagnostic 
correlations are clearly evident at high sensitivity even at short mixing times (4 ms 
TEDOR, 50 to 100 ms DARR) (Fig. 5.6).  We converted the cross peak intensities into 
internuclear distance restraints according to our prior studies24,25. In addition to the 
distance restraints, TALOS-N analysis provided 106 backbone dihedral restraints (Fig. 
5.7)26. 
 
5.4.3 α-Syn fibrils adopt a Greek-key topology structure 
To determine a unique 3D structure consistent with all NMR data and other 
known structural features, we implemented simulated annealing calculations within 
XPLOR-NIH27, configuring the distance potential to consider explicitly the contributions 
from both intramolecular as well as intermolecular distances from each of the 10 
protomers (for restraints that were measured on undiluted samples). This approach avoids 
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the bias of assuming that individual pairs of nuclei give rise to the observed correlations, 
and resulted in a single backbone fold consistent with the available experimental data. 
The resulting structure adopts a β-serpentine arrangement with a Greek-key β-
sheet topology.  In detail, the arrangement here exhibits hydrogen bonds in register along 
the fibril axis, which is perpendicular to the hydrogen bond arrangement in a standard 
Greek-key motif28 (Fig. 5.8a-d, Fig. 5.9). The innermost β-sheet of the core includes 
residues 71-82, which are necessary and sufficient for fibril formation24. Side chains in 
the core are tightly packed and uniquely positioned (Fig. 5.8a, Fig. 5.8d). Although the 
stagger of individual side chains is not uniquely determined13, the lowest energy 
structures (for example, as shown in Figure 3a) exhibit short distances between F94 and 
I88 (Fig. 5.10, 5.11), and between K80 and E46 (Fig. 5.10, 5.11), of neighboring 
molecules. In two instances, compact residues facilitate a close backbone-backbone 
interaction:  (1) A69-G93 bridges the distal loops of the Greek key, and (2) A78-G47 
adopts a geometry in which a stable intermolecular salt bridge is formed between E46 
and K80 (Fig. 5.5, 5.10, 5.11). Hydrophobic side chain packing among F94, A91 and I88 
establish the innermost portion of the Greek-key (Fig. 5.10, 5.11). V82, V77, A89, and 
A90 comprise a pocket in which the Q79 side chain forms a glutamine ladder along the 
fibril axis (Fig. 5.11) through intermolecular hydrogen bonds, an interaction known to be 
stabilizing in amyloid fibrils13. The turns consist mostly of Gly and Ala residues (G67-
G68-A69, G73, G84-A85-G86, A89-A90-A91).  Residues 55 to 62 are disordered, 
consistent with the incomplete resonance assignments and slightly reduced order 
parameters in this region as measured by Comellas et al. (Fig. 5.8e)7. The core of the 
fibril (residues 46 to 54 and 63 to 96) is well structured (1.5 Å backbone RMSD), 
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consisting mostly of hydrophobic residues with well-defined side chain positions (2.0 Å 
full heavy atom RMSD) (Fig 5.8e, Table 2), consistent with all observed NMR restraints 
(Fig. 5.12) and torsion angles for restrained residues (Fig. 5.13).   
 
5.4.4 Structural validation  
Low-resolution structural characterization by bright-field negatively stained 
transmission electron microscopy (TEM) (Fig. 5.14a) of single, isolated fibrils 
demonstrates features of highly homogeneous, microscopically ordered fibrils with a 
width of 4.6 ± 0.4 nm. This result is consistent with prior results from our lab7 as well as 
other α-syn fibril studies29-31. Further, we applied scanning transmission electron 
microscopy (STEM) measurements to obtain a mass-per-length ratio of 34.45 ± 2.95 
kDa/nm (Fig. 5.14b), supporting an in-register parallel β-sheet structure with one 
protomer per β-sheet spacing32. The narrow error on our mass-per-length ratio, in 
conjunction with our narrow SSNMR linewidths (~0.2 ppm) is indicative of a highly 
homogenous fibril sample that adopts a single conformation. To further ensure that the 
fibrils used in the STEM measurements were in the same conformation as those used in 
the SSNMR study, we prepared a sample of fibrils using the same buffer and sonication 
conditions for the EM sample preparation and confirmed that the chemical shifts were 
identical, indicating that the two samples have the same structure (Fig. 5.15). X-ray fiber 
diffraction patterns (Fig. 5.14c) from our fibril form exhibit the archetypal amyloid 
meridional diffraction at 4.8 Å indicating a cross-β structure. Strong intensity on the 
equator at about 10 Å resolution is typical of diffraction patterns from amyloids in which 
β-sheets are stacked together. In this case, the intensity is divided into three strong peaks, 
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whose center of mass corresponds to an average β-sheet separation of 9.1 Å.  The 0.02 Å-
1 spacing of the three peaks indicates an average diameter of the diffracting unit of ~50 
Å. The width of the structured fibril core from Figure 3 is 4.5 nm, and the average β-
sheet separation is ~8.9 Å, in excellent agreement with the STEM and fiber diffraction 
results. 
 
5.5 Discussion 
The α-syn fibril structure exhibits many of the stabilizing features of common 
amyloid folds,11,14,16,33 including parallel in-register β-sheet hydrogen bonding, an 
intermolecular salt bridge (E46-K80), steric zippers involving the hydrophobic sidechains 
(such as V48, V82, and V77), a glutamine ladder (Q79) along the fibril axis, and tight 
packing of an aromatic residue in a hydrophobic pocket (F94 and I88). Nevertheless, the 
α-syn fibril structure is considerably more complex than the earliest predicted β-
serpentine models of α-syn fibrils29. More recently, the structural model for the core of 
α-syn fibrils proposed by Rodriguez et al. from micro-electron diffraction structures of 
peptides simulating the core of α-syn fibrils similarly contains a steric zipper as is 
commonly found in amyloid fibril structures, but is similarly comprised of mostly 
extended β-sheets. In this case, the peptides used in their study lack the residues that most 
predominately contribute to the folding of the Greek key topology, including E46, Q79, 
K80, I88, A91, and F94. Indeed, structural complexity has been identified in general as 
an important factor in the stability of self-propagating amyloid fibrils34. For α-syn in 
particular, we note that the especially compact Greek-key topology is facilitated by a 
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large fraction of small, flexible amino acid residues (Gly, Ala or Ser) in the core of the 
fibril.  Not only within the Lys-Thr-Lys-Glu-Gly-Val repeats, but also in the intervening 
residues, these sequence motifs enable α-syn to adapt from an intrinsically unstructured 
protein in solution35 to a well ordered hairpin of tightly pitched helices in complex with 
lipid bilayers and to the particular arrangement in the fibril core as observed here. 
Specifically, almost 40% residues in the a-syn fibril core (18 out of 50) are Gly, Ala or 
Ser, whereas only 8 out of the 42 residues in amyloid-β and 9 out of the 32 residues in the 
Het-S structured core are composed of these small residues.11,16,33 We therefore attribute 
the novel yet highly specific ordering of the fibril core in part to the prevalence of small 
residues. It is likely that many of the long β-sheets identified in other studies are not fully 
extended and adopt a more compact arrangement due to this high prevalence of residues 
with small sidechains that can maintain β-sheet dihedral angles while relieving the 
energetic strain of straight extended parallel β-sheets, which are rarely longer than 7 
amino acids36.  
α-Syn fibrils isolated from the substantia nigra of PD patient brains have a 
diameter of ~5 nm for single untwisted fibrils37, consistent with our measurement of 4.6 
nm in the structure and supported by our EM and fiber diffraction data. The spacing of 
the three distinct strong peaks on the equator in our fiber diffraction pattern (Fig. 4c) 
corresponds to a narrow single fibril unit.  Other studies have identified fibrils that are 
significantly wider (~12 nm)10, which could be attributable to the twisting of 2-3 
individual fibrils or a domain-swap interaction of several protomers per β-sheet layer as 
has been observed in amyloid-β13. SSNMR studies on these alternative α-syn fibril forms 
have identified different secondary structure elements, most notably near residues 45, 74 
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and 82 which in some forms, such as ours, are in β-sheets, while others report them as 
being in loop regions38. Based on these differences, it is likely that these additional fibril 
forms adopt different tertiary core structures from the one in this work that would lead to 
the differences observed in SSNMR, EM, and fiber diffraction data. 
Missense mutations of α-syn, including A30P, E46K, H50Q, G51D and A53T, 
have been implicated as early-onset PD mutants that cause the onset of PD symptoms 
years earlier than in sporadic cases39-41. Previous work by some of us presented the 
chemical shifts of three of the early-onset PD mutants: A30P, E46K, and A53T, as well 
as the chemical shifts of fibrils grown in the presence of phospholipids40-42. In the cases 
of A30P and A53T, we observed that the chemical shifts were nearly identical to those of 
this form with only small perturbations to sites proximal to the mutation40,41. In the 
presence of phospholipids we again noted that the chemical shifts were largely 
unchanged, with differences localized to the N-terminal residues that are known to 
directly interact with lipids42. The lack of perturbations in the chemical shifts reveals that 
the structure of these different fibril samples must be very similar. With the E46K 
mutant, however, we noticed large chemical shift perturbations for many sites throughout 
the core of the fibril, suggesting a substantial change in fibril structure41. Our 3D 
structure demonstrates that residues E46 and K80 form an intermolecular salt bridge that 
is further stabilized by interactions among the neighboring residues. We expect that the 
E46K mutant would not accommodate this same conformation. Additionally, a previous 
SSNMR study of fibrils formed from mouse α-syn identified a secondary structure that is 
highly similar to the form in this work43. 
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We envision that the α-syn fibril structure presented here will enable the rational 
development of improved ligands for diagnosis of PD and development of biomarker 
assays, as well as an improved understanding of the biochemical mechanisms underlying 
templated recruitment and propagation in α-synucleinopathies. This idea has been 
demonstrated in the case of Aβ fibrils implicated in Alzheimer’s disease (AD), where 
seeding monomeric Aβ with material from AD patients brains can lead to different 
strains with structural changes that are associated with different disease progression 
patterns14. Such atomic-resolution Aβ fibril structures have enabled structure-based 
discovery of small molecule ligands that bind longitudinally44.  In the case of α-syn 
fibrils, phenothiazine derivatives have been identified as lead compounds for positron 
emission tomography imaging45. In the structure, we see exposed surfaces on β-sheets 
surrounding the central non-amyloid component of the core including residues 46–67 and 
82–86 that may be potential binding regions for compounds such as these, while a 
majority of the residues in the non-amyloid component residues are inaccessible, 
consistent with proteinase-K digestion studies of α-syn fibrils46. Other studies have 
established that two other strains of α-syn fibrils possess different secondary structures, 
levels of toxicity, and propagation properties, which may have different exposed regions 
in their fibril structures6,10.  The structure reported here will facilitate an understanding of 
the structural differences among α-syn fibril strains, improve the mechanistic 
understanding of templated recruitment and propagation in α-synucleinopathies, and 
establish a basis for the rational design of imaging agents and PD drug candidates. 
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5.6 Data Deposition 
Coordinates have been deposited in the Protein Data Bank under accession 
number 2N0A and chemical shifts have been deposited to the Biological Magnetic 
Resonance Bank under entry 25518.  
5.7 Methods 
5.7.1 α-Syn Sample Preparation for SSNMR Studies   
Samples of α-syn protein used in this study were expressed and purified as 
described previously13. The expression protocol of Marley et al.47 was modified for 
sparse labeling using a glycerol carbon source48 as follows: A preculture of E.coli 
BL21(DE3)/pET28a-AS was prepared in Studier medium M49 containing 2 g/L NH4Cl, 2 
g/L glycerol, 1 ml/L BME vitamins (Sigma-Aldrich no. B6891), and kanamycin. The 
culture (200 ml/2-L baffled flask) grew with shaking (250 rpm) at 37 °C to a cell density 
of near saturation (A600 = 2.2-2.7). Cells were then collected by centrifugation at 25 °C 
and resuspended in half the original culture volume of fresh medium M containing 2 g/L 
15NH4Cl, and either 4 g/L 1,3-13C-glycerol and 1 g/L Na2CO3 or 4 g/L 2-13C-glycerol and 
1 g/L Na2-13C-CO3. The sodium carbonate was added to prevent isotopic dilution due to 
reversible carboxylase activity48. The resuspended culture (100 ml/1-L flask) was shaken 
for 30 min at 25 °C, and induced with 0.5 mM IPTG. Cells were harvested at 13 h. The 
cell density at induction was A600 = 5 to 6, and at harvest, 7 to 9. Protein was purified 
using hydrophobic interaction chromatography and size exclusion chromatography17 with 
a yield of 130-150 mg α-syn per L culture medium. Isotopically-labeled glycerol,  (1,3-
13C and 2-13C) ammonium chloride and sodium 13C-carbonate were purchased from 
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Cambridge Isotope Laboratories, Andover, MA. The monomer solution was concentrated 
to a solution of 15 mg/mL in phosphate buffer, and was fibrillized at 37 °C with shaking 
for 3 weeks, after which the fibrils were pelleted, washed with DI H2O, dried under N2 
gas overnight and packed into 3.2 mm rotors as described by Comellas et al.7.  
 
5.7.2 Solid-State NMR Spectroscopy 
Magic-angle spinning (MAS) solid-state NMR experiments were conducted at 11.7 
T (500 MHz 1H frequency), 14.1 T (600 MHz), and 17.6 T (750 MHz) on Agilent 
Technologies VNMRS (500 and 750 MHz) and InfinityPlus (600 MHz) spectrometers 
using 3.2 mm Balun probes. Spinning was controlled with a Varian MAS controller to 
11,111 ± 3 Hz (500 MHz 1H frequency), 10,000 kHz or 13,333 kHz (600 MHz 1H 
frequency), and 12,500 Hz (750 MHz 1H frequency). Typical pulse widths after 
optimization were ~2-2.5 µs for 1H, ~3 µs for 13C, and ~5 µs for 15N. We used 75-80 kHz 
SPINAL decoupling during evolution and acquisition50.  Experiments were performed at 
a variable-temperature (VT) setting of 10 °C, which is calibrated by ethylene glycol to a 
sample temperature of 12-17 °C. Chemical shifts were externally referenced using 
adamantane with the downfield peak set to 40.48 ppm51. Chemical shifts for each sample 
were confirmed to agree with those previously reported7 using 2D 13C-13C, 3D 15N-13C-
13C, 13C-15N-13C and 13C-13C-13C correlation experiments. 
 
5.7.3 Solid-State NMR Data Processing 
Spectra were processed with NMRPipe52 with back linear prediction with a 
polynomial baseline correction to the first dimension. Lorentzian-to-Gaussian 
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apodization, cosine bells, and/or zero filling were applied in each dimension prior to 
Fourier transformation. The spectra were analyzed in Sparky53. 
 
5.7.4 XPLOR-NIH Structure Calculations 
XPLOR-NIH version 2.33.4 was used for structure calculations. Ten extended 
protomers of full-length α-syn were aligned along the z-axis with a 20 Å separation from 
one protomer to the next. Structured residues (30 to 95) were restrained to take identical 
structure in each subunit using non-crystallographic symmetry restraints implemented 
using XPLOR-NIH’s PosDiffPot term, as we observed a single chemical shift for each 
residue in this core region, indicating a single structure. NOE restraints from samples 
where it was not possible to determine whether a correlation was inter- or intramolecular 
were included in a separate potential by setting nMono to 10 within the NOE potential, 
avoiding the bias of assuming that individual pairs of nuclei give rise to the observed 
correlations. Restraints that were explicitly intermolecular or intramolecular were 
included in NOE potentials with nMono set to 1 with a copy of each restraint for each 
protomer. Because the distance restraints were applied to all subunits, translational 
symmetry was thus implicitly applied. The initial annealing calculation of 256 structures 
started at 5000 K with a high temperature dynamics run for 10 ps or 5000 steps, 
whichever comes first, beginning with a 0.001 ps timestep that self adjusts depending on 
energy conservation from one step to the next. After the high-temperature calculation, the 
temperature was reduced to 20 K in steps of 20K. At each temperature step, a trajectory 
was run 0.4 ps or 500 steps, whichever came first, with an initial 0.001 ps timestep.  To 
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aid in core packing, a gyration volume term54 was applied to residues 46-94 of all 
subunits. 
The empirical hydrogen bond database54 and a statistical torsion angle potential55 
were utilized in addition to terms for bond lengths, bond angles and improper angles. 
After the initial structure calculation phase, each structure was refined using slow 
annealing from 3000 K to 20 K in 4 K steps. Force constants for the restraint terms were 
ramped as follows: ambiguous distance restraints were ramped from 0.01 to 40 
kcal/mol/Å2 in the initial phase and from 40 to 50 kcal/mol/Å2 in the refinement phase; 
unambiguous distance restraints were ramped from 0.01 to 20 kcal/mol/Å2 in the initial 
phase and from 20 to 25 kcal/mol/Å2 in the refinement phase; dihedral restraints were 
ramped from 10 to 150 kcal/mol/rad2 in the initial phase and from 150 to 300 
kcal/mol/rad2 during refinement; the gyration volume was scaled from 10-3 to 0.1 during 
the initial phase and from 0.1 to 5 during refinement. From the resulting 256 structures 
we took the best 32 structures based on their relative energies for further analysis. In each 
of the structures the backbone and relative side chain orientations were identical, but 
because the XPLOR-NIH calculation did not explicitly specify whether a restraint was 
intermolecular or intramolecular, there was a differing degree of structurally distinct 
intermolecular side chain packing (the intrafibril quaternary structural features). Similar 
quaternary contacts have been observed in previous studies with Aβ13. For instance, data 
supports an intermolecular side chain interaction between K80 and E46, but we could not 
uniquely determine whether the stagger of those side chains would be +1 or -1. We 
observed this same phenomenon with the I88-A91-F94 interactions, with three different 
populations of intermolecular side chain orientations, one with moderate side chain 
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interactions with a + orientation, as well as the +1 and -1 side chain stagger. The structure 
presented in the main text corresponds to the most highly populated state in the XPLOR-
NIH calculations, with a moderate + stagger for the aromatic side chain of F94 and a +1  
stagger for K80. The resulting structure had 77.2% of residues in the most favored 
Ramachandran space, 18.1% in allowed regions, 3.1% in generous regions, and 1.6% in 
disallowed regions. However, all residues with disallowed Ramachandran conformations 
were in disordered, unrestrained termini. 
 
5.7.5 Primary neuronal cultures and fibril transduction 
Primary neuronal cultures were prepared from E15-E17 embryos of CD1 mice 
(Charles River). All procedures were performed according to the NIH Guide for the Care 
and Use of Experimental Animals and were approved by the University of Pennsylvania 
Institutional Animal Care and Use Committee (IACUC). Dissociated hippocampal 
neurons were plated onto poly-D-lysine coated 13mm coverslips in a 24 well plate at 
100,000 cells/coverslip and allowed to mature for 10 days. Pre-formed fibril (PFF) 
transduction was performed at 10 days in vitro, whereby α-syn PFFs were diluted to 2.3 
µM or 0.23 µM  (33.3 µg/ml or 3.3 µg/ml) in dPBS –Mg -Ca and sonicated for 5 min on 
the high setting with a Diagenode Biorupter™ (30s on, 30s off, 10°C bath temp). In total, 
11 samples of each dilution were independently prepared. Neurons were then treated with 
PBS or sonicated PFFs to give final α-syn concentrations of 0, 9.4, 17.3, 34.6, 69.2, 138, 
277, and 415 nM. Three coverslips were transduced at each concentration. Beginning at 4 
days post transduction, 200 µL of the media was carefully removed from each well and 
transferred to a 96 well plate and frozen for later cytotoxicity testing. 200 µL of fresh, 
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pre-warmed neuronal media was then added back to each well. Transduced neurons were 
harvested for immunocytochemistry at 18 days post transduction (28DIV). 
 
5.7.6 Immunocytochemistry 
Neurons were fixed and permeabilized with pre-warmed 4% paraformaldehyde 
(PFA) in PBS containing 4% sucrose and 1% Triton X-100 for 15 min to remove soluble 
proteins. After blocking with 3% BSA and 3% FBS in PBS for at least 1 hr at room 
temperature, neurons were incubated with 81A (pSer129 α-syn) and SynA (total 
synuclein) overnight at 4 °C followed by staining with appropriate Alexa fluor 594 or 
488-conjugated secondary antibodies (Invitrogen) for 2 h at room temperature. 
Coverslips were then mounted on to glass slides with eBioscience Fluoromount G™ with 
DAPI and scanned on a Perkin Elmer Lamina™ scanner. Quantification was performed 
using Indica Labs HALO™ software ((area occupied x average intensity)/DAPI count) 
and data is reported as an average of three coverslips. Graphing (Figure 1B) was 
performed with Graphpad Prism 4™, bar = SEM 
 
5.7.7 Cytotoxicity Assay  
 Toxicity was assessed using media sampled from neurons every other day 
beginning at 4 days post transduction through 18 days post transduction using the 
Pierce™ LDH Cytotoxicity assay kit per the manufacturer’s instructions. Data was 
recorded using a Molecular Devices Spectramax™ plate reader. Graphing (Figure 1C) 
was performed using Graphpad Prism 4 and statistical significance was determined with 
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the same software using a two-way analysis of variance with Bonferroni correction. * = p 
< 0.05, ** = p < 0.01, bar = SEM 
 
5.7.8 Preparation of the fibrils for TEM and STEM 
After ultracentrifugation, the pellet was resuspended in 20 mM HEPES buffer (pH 
7.4, 0.02 % sodium azide and 0.1 mM EDTA) and ultracentrifuged. This cycle was 
repeated several times and the final solution was sonicated (600 volts, 5 Amps.) three 
times using 1 min. pulses.  
 
5.7.9 Transmission Electron Microscopy 
Negatively stained α-syn samples for transmission electron microscopy (TEM) were 
prepared by resuspending the fibrils in 20 mM HEPES buffer (pH 7.4, 0.02 % sodium 
azide and 0.1 mM EDTA); Karnovsky’s fixative was added and a drop was placed over 
Parafilm. A formvar carbon coated grid (300 mesh) was positioned face down on the 
drop for 15 min to absorb the fibrils. The grid was then placed for 2.5 min in a drop of 
0.2 % ammonium molybdate (w/v) for negative staining, wicked in a drop of water and 
allowed to dry. Electron micrographs were recorded in a Hitachi H600 Transmission 
Electron Microscope, operating at 75 kV. 
 
5.7.10 Scanning Transmission Electron Microscopy (STEM). 
α-syn samples for STEM were prepared using the wet film approach with freeze-
dried specimens according to the standard methodology of the Brookhaven STEM 
facility (www.biology.bnl.gov/stem/stem.html), which is described as follows. 2.3 mm 
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titanium grids were coated with thick holey carbon film that supported a thin carbon film. 
The thin carbon film was prepared by ultra-high vacuum evaporation onto a freshly 
cleaved crystal of rock salt and floated on a dish of clean water to avoid unspecific 
absorption of material. Grids were then positioned face down on the floating thin carbon 
films and picked such as the thin carbon film retained a droplet of water. This water was 
exchanged by washing with injection buffer containing 2 µL of tobacco mosaic virus 
(TMV) as quantitative internal control at a concentration of 100 µg/mL, incubated for 1 
min and washed four times. Three different grids were prepared by adding 2 µL of α-syn 
fibrils at the concentrations of 120 µg/mL, 300 µg/mL and 1200 µg/mL in 20 mM 
HEPES buffer, respectively, incubated for 1 min and washed ten times with the buffer 
and water. After the final wash, the grid was pinched between two pieces of paper filters 
and immediately plunged into liquid nitrogen slush. The grids were then transferred 
under liquid nitrogen to an ion-pumped freeze dryer with an efficient cold trap, freeze-
dried overnight by gradually warming to -80°C and transferred under vacuum to the 
STEM. Dark-field micrographs were recorded on a custom-built STEM, operating at 40 
kV, with a probe focused at 0.25 nm and a sample temperature of -150°C. 
 
5.7.11 Mass-per-length measurement and analysis of STEM images 
Dark-field STEM micrographs with 512 x 512 points and a dwell of 30 µs per pixel 
were analyzed using the PCMass software available from the Brookhaven STEM 
resource (http://www.bnl.gov/biology/stem/Data_Analysis.asp)56. The mass-per-length 
(MPL) measurements were conducted using boxes of 30 nm length and the appropriate 
widths from the #21 (TMV) and #55 (amyloid) fitting functions, respectively, from 
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PCMass31.  The fitting function was used for alignment and quality control only and had 
no effect on measured MPL. The resulting data were normalized to the known MPL of 
TMV (131.4 kDa/nm). Histograms of the α-syn fibrils MPL measurement were 
calculated with 1-kDa/nm bins and the main peak was fitted to a Gaussian distribution 
using the Marquardt-Levenberg algorithm, as implemented in Sigma Plot (Systat 
Software). 
 
5.7.12 Measurement of the variation in fibril width along its length 
STEM images were also used to measure the variation of the fibril widths in steps of 
5-nm along the fibrils using the PCMass software56. At each step, the fibril density was 
determined by averaging each point with the 5 nm length of fibril in each direction to 
increase the signal-to noise. As previously demonstrated for HET-s57, fibrils composed of 
multiple single fibrils wound round each other vary systematically in projected diameter 
along their length, while for double fibrils consisting on two singlet fibrils, the projected 
diameters varies from a single fibrils diameter to twice that measurement.  
 
5.7.13 X-ray Fiber Diffraction 
Fibers were prepared58 by suspending a 5–10 µl drop of fibril suspension between 
two glass rods approximately 1.5 mm apart. The fibers were allowed to dry for several 
days in a closed chamber under high humidity (nominally 100% in equilibrium with 
water). Diffraction data were collected at beamline 4-2 at the Stanford Synchrotron 
Radiation Laboratory. Fibers were dusted with calcite and specimen-to-detector distances 
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were determined from the 012 calcite diffraction ring at 3.8547 Å resolution59. 
Diffraction patterns were analyzed using the program WCEN60. 
5.8 Tables 
 
Table 5.1 | Summary of samples used to determine the structure of α-syn fibrils, the 
structural information each sample provided, and the number of restraints from these 
samples. 
α-Syn Fibril Sample ID Restraint Type No. 
Restraints 
Uniform-13C, 15N A Intraresidue 807 
  Interresidue 562 
  Medium-range 32 
  Long-range 5 
1,3-13C-Glycerol, 15N B Intraresidue 1320 
  Interresidue 1449 
  Medium-range 595 
  Long-range 131 
2-13C-Glycerol, 15N C Intraresidue 765 
  Interresidue 1079 
  Medium-range 223 
  Long-range 164 
25% U-13C, 15N, 75% natural 
abundance* D Intraresidue 329 
  Interresidue 83 
  Medium-range 33 
  Long-range Intramolecular 5 
50% 1,3-13C-Glycerol, 50% 
15N† E Intermolecular Registry 58 
50% 2-13C-Glycerol, 50% 
15N† F Intermolecular Registry 64 
  Total Assigned Peaks 7704 
* This isotope labeling scheme provides strictly intramolecular interactions 
†This isotope labeling scheme provides strictly intermolecular interactions 
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Table 5.2 Summary of data collected on the a-syn fibril samples. The sample ID 
corresponds to those listed in Table 1.
 
  
Sample Experiment Magnet MAS Rate (kHz) Mixing Exp Time (hr) 
A 2D 13C-13C with DARR mixing 17.6 T (WB) 12.5 25 ms 3.55 
A 2D 15N-{13CO}-13CX with DARR mixing 17.6 T (WB) 12.5 25 ms 7.1 
A 2D 15N-{13CA}-13CX with DARR mixing 17.6 T (WB) 12.5 25 ms 7.1 
A 2D 13CA-{15N}-{13CO}-13CX with DARR mixing 17.6 T (WB) 12.5 50 ms 30.24 
A 3D 13CA-{15N}-13CO 17.6 T (WB) 12.5  3.55 
A 3D 15N-13CA-13CX with DARR mixing 17.6 T (WB) 12.5 50 ms 58.0 
A 3D 15N-13CO-13CX with DARR mixing 17.6 T (WB) 12.5 50 ms 28.72 
B 3D 15N-13CO-13CX with DARR mixing 11.7 T (WB) 11.111 500 ms 181.25 
B 2D 13C-13C with DARR mixing 11.7 T (WB) 11.111 500 ms 64.8 
B 2D 13C-13C with DARR mixing 11.7 T (WB) 11.111 150 ms 49.84 
B 2D 15N-13C with TEDOR mixing 14.1 T (WB) 10.0 1.6 ms, to 16.0 ms  0.5 days each 
B 2D 15N-13C with TEDOR mixing 14.1 T (WB) 10.0 1.6 ms, to 16.0 ms 1 Day Each 
B 2D 13C-13C with DARR mixing 14.1 T (WB) 10.0 500 ms 17.82 
B 3D 15N-13CO-13CX with DARR mixing 14.1 T (WB) 13.333 500 ms 159.2 
B 2D 13C-13C with DARR mixing 14.1 T (WB) 13.333 750 ms 60.7 
B 2D 13C-13C with DARR mixing 14.1 T (WB) 10.0 50 ms to 500 ms 11.2 to 41.8 
B 2D 13C-13C with DARR mixing 17.6 T (NB) 12.5 50 ms to 500 ms 5.65 to 14.04 
B 3D 15N-13CO-13CX with DARR mixing 17.6 T (NB) 12.5 50 ms 11.43 
B 3D 15N-13CO-13CX with DARR mixing 17.6 T (NB) 12.5 100 ms 23.56 
B 3D 15N-13CO-13CX with DARR mixing 17.6 T (NB) 12.5 200 ms 24.98 
B 3D 15N-13CO-13CX with DARR mixing 17.6 T (NB) 12.5 300 ms 26.4 
C 3D 15N-13CA-13CX with DARR mixing 11.7 T (WB) 11.111 500 ms 152.11 
C 2D 13C-13C with DARR mixing 14.1 T (WB) 10.0 100 ms to 500 ms 16.86 to 47.68 
C 2D 15N-13C with TEDOR mixing 14.1 T (WB) 10.0 1.6 ms to 16.0 ms 1 Day Each 
C 3D 15N-13CA-13CX with DARR mixing 17.6 T (WB) 12.5 500 ms 87.72 
C 3D 15N-13CO-13CX with DARR mixing 17.6 T (WB) 12.5 500 ms 34.95 
C 3D 13CA-15N-13CO 17.6 T (WB) 12.5 N/A 18.72 
C 2D 13C-13C with DARR mixing 17.6 T (WB) 12.5 250 ms 2 
C 2D 13C-13C with DARR mixing 17.6 T (WB) 12.5 500 ms 22.1 
C 3D 13C-13C-13C with DARR mixing 17.6 T (WB) 12.5 250 ms, 500ms 306 
C 3D 15N-13CA-13CX with DARR mixing 17.6 T (WB) 12.5 750 ms 230.16 
C 3D 15N-13CO-13CX with DARR mixing 17.6 T (WB) 12.5 750 ms 99.85 
D 2D 15N-13C with TEDOR mixing 11.7 T (WB) 11.111 16 ms 81.2 
E 2D 15N-13C with TEDOR mixing 11.7 T (WB) 11.111 16 ms 124.04 
F 2D 13C-13C with 1H-1H mixing 17.6 T (WB) 12.5 400 us 283.1 
F 2D 13C-13C with DARR mixing 17.6 T (WB) 12.5 50 ms 20 
    
Total Time 3049.3 
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Table 5.3 NMR and refinement statistics for protein structures 
 
 α-syn fibrils 
NMR distance and dihedral constraints per 
protomer 
 
Distance restraints  
    Total  405 
    Inter-residue  
      Medium range (1 < |i-j| < 5)   90 
      Long-range (|i-j| ≥ 5)    205 
      Intermolecular 110 
Total dihedral angle restraints  
    Phi 45 
    Psi 45 
  
Structure statistics from lowest 32 structures  
Violations (mean and s.d.)  
    Distance restraints ≥ 5 Å (Å)     0.58 ± 0.05 Å 
    Dihedral angle restraints ≥ 5° (°) 8.6 ± 3.1° 
    Max. dihedral angle violation (°)     18.44° 
    Max. distance restraint violation (Å)  0.64 Å 
Deviations from idealized geometry  
    Bond lengths (Å)     0.06 ± 0.019 Å 
    Bond angles (°) 5.3 ± 0° 
    Impropers (°) 0.0 ± 0.0° 
Average pairwise r.m.s.d.** (Å)      
    Heavy      2.04 Å 
    Backbone  1.48 Å 
**Pairwise r.m.s.d. was calculated among 10 refined structures for structured residues 46 to 54 and 63 to 
96. Residues 54 to 62 are disordered. 
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5.9 Figures
 
Figure 5.1. α-Syn PFFs prepared in vitro have a dose dependent effect on neurons. 
(a.) Treatment of non-transgenic mouse primary hippocampal neurons with preformed α-
syn fibrils results in progressive accumulation of LB- and LN-like insoluble, 
phosphorylated α-syn (pSyn, red) protein, as detected by immunostaining with 
phosphorylated Ser129 specific (81A) antibody. Soluble proteins were removed during 
fixation. Nuclei were visualized with DAPI (blue). Importantly, under these conditions, 
untreated neurons show no pSyn signal (upper left), pSyn signal in treated neurons co-
localizes well with a pan synuclein antibody (SynA, green, bottom row, merged 81 and 
SynA orange), and the fibrils themselves can be immunostained by the pan synuclein 
antibody but not the pSyn antibody when transduced onto a coverslip with no neurons 
present (bottom right). (b.) Quantitation of coverslips treated with increasing amounts of 
α-Syn fibrils reveals a sigmoidal increase in insoluble, pSyn with rising dose of treated 
fibrils (c.) Monitoring LDH released into the media of primary neuronal cultures 
demonstrates that α-syn fibirls are toxic at high doses of fibril treatment after extended 
exposure. * = p<0.05, ** = p<0.01 bar = SEM 
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Figure 5.2 | Mass Spectrometry and Solution NMR data identifying the samples as 
α-syn. a, MALDI-TOF mass spectrum of isotopically labeled α-syn monomer (blue) and 
natural abundance monomer (red) prior to fibrillization. The molecular weight of natural 
abundance α-syn monomer is calculated to be 14.46 kDa, agreeing with our experimental 
mass spectrum, and corresponds to a ~98% incorporation of 13C and 15N during protein 
expression for our labeled samples. b, 15N, 1H HSQC of monomeric α-syn prior to 
fibrillization. The chemical shifts are consistent within experimental conditions with 
those previously reported. 
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Figure 5.3 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. 
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Figure 5.4 | 15N, 13C SSNMR TEDOR data showing intermolecular interactions. The 
data was collected with mixing times of 14.4 ms on a, uniformly 1,3-13C glycerol 15N 
labeled and b, 50:50 1,3-13C glycerol, natural abundance (n.a.) nitrogen: n.a. carbon, 15N 
labeled a-syn and c, uniformly 2-13C glycerol 15N labeled and d, 50:50 2-13C glycerol, 
n.a. nitrogen: n.a. carbon, 15N labeled a-syn. Most of the crosspeaks present in B are 
present in A, representing a largely symmetric in-register arrangement, with some side 
chain interactions that appear to be intermolecular, such as A78N-V82CG2 and Q79NE2-
V82CG1, as they do not appear in A. The similarity between C and D support a parallel 
in-register arrangement, as the crosspeaks representing Ca correlations in D are also 
present in C. 
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Figure 5.5 | Long-range structural restraints defining the atomic-resolution 
structure of α-syn fibrils. a-f, Solid-state NMR spectra of isotopically labeled α-syn 
fibrils. Red labels indicate long-range distance restraints; black labels represent 
intraresidue and sequential correlations. Data were collected at 750 MHz 1H frequency 
with sample B, 12.5 kHz MAS rate, unless otherwise noted. 2D planes from 15N-13CO-
13CX spectrum with 500 ms DARR mixing for the a, G93C resonance in F3 and b, 
A78CB resonance in F3. c, Aromatic-to-aliphatic region 2D 13C-13C spectrum, 300 ms 
DARR mixing. d, 2D plane from 15N-13CO-13CX spectrum with 500 ms DARR mixing 
for the Q79CB resonance in F3. e, 2D plane from a 15N-13CA-13CX spectrum of sample C 
with 500 ms DARR mixing. f, Region of 15N-13C spectrum for sample B with 6.4 ms 
TEDOR mixing (600 MHz 1H frequency and 10 kHz MAS rate). 
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Figure 5.6 | SSNMR data of a-syn fibrils showing long-range restraints at series of 
mixing times. Red labels indicate long-range distance restraints while black labels 
represent intraresidue and near-neighbor correlations. All spectra acquired at 750 MHz 
1H frequency a, 2D plane from a 15N-13CO-13CX correlation spectrum with 100 ms 1H 
DARR mixing. b, 2D plane from a 15N-13CO-13CX correlation spectrum with 100 ms 
DARR mixing on a 1,3-13C-glycerol labeled sample. c, 15N-13C TEDOR data collected on 
dilute and fully 2-13C-Glycerol labeled samples showing an intermolecular crosspeak 
between K80 and E46. The presence of the K80 Nζ to E46 Cδ cross peak in both spectra 
shows that these side chain interactions are intermolecular. d, 50 ms DARR mixing 
shows initial long-range restraints e, 100 ms DARR mixing f, 200 ms DARR mixing g 
300 ms DARR mixing spectrum shows 8 long range correlations (red) between the F94 
side chain and I88, A90 and A91.  
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Figure 5.7 | TALOS-N results for a-syn fibrils. a, Backbone dihedral angles (Phi and 
Psi) as predicted by TALOS-N. b, The order parameter for the core region of a-syn 
fibrils. 
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Figure 5.8 | The 3D structure of α-syn fibrils. a, View of a central protomer from 
residues 44 to 96 looking down the fibril axis showing the Greek-key motif of the fibril 
core. b, A view of the stacked protomers showing the sidechain alignment between each 
protomer down the fibril axis  c, Residues 20 to 110 of 8 protomers showing the β-sheet 
alignment of each protomer in the fibril and the Greek-key topology of the core. d, 
Overlay of the 10 lowest energy structures showing agreement of side chain positions 
within the core corresponding to an RMSD of 2.0 Å for all heavy atoms for residues 46 to 
54 and 63 to 96. Residues 52 to 67 are disordered and shown in red with sidechains 
removed for clarity. 
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Figure 5.9 | Full-length structure of a-syn fibrils including disordered tails.  a, View 
looking down the fibril axis showing the highly ordered core and the disordered tails. b, 
Side view of the structure showing the b-sheet packing between each protomer as well as 
the disordered tails. 
 
 
 
Figure 5.10 | Expansions of the a-syn fibril structure with restraints. Dotted grey 
lines correspond to SSNMR distance restraints a, Restraints establishing the V48-A78 
interactions b, The Q79 glutamine ladder and hydrophobic pocket. c, A69 is in close 
proximity to G93 and F94  d, The F94-A91-I88 pocket with close interactions with the 
I88 and F94 sidechains. 
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Figure 5.11 | Side chain interactions demonstrating large intermolecular 
interactions. The backbone trace for separate protomers is shown in tan, yellow, orange, 
and grey. a, A view of the I88-A91-F94 pocket perpendicular to the fibril axis. The 
orientation of the F94 aromatic ring shows instances where the I88 Cδ1 from the i+1 
protomer is closer than the intramolecular I88 Cδ1. b, Top view of the I88-A91-F94 
interactions showing the close proximity of the side chains. c, +1 staggered side chain 
where K80 is interacting with the i+1 protomer in the fibril, forming a salt bridge. d, Top 
view of the E46 and K80 interactions showing that the side chains are well aligned along 
the fibril axis. e, Side view of the Q79 side chain showing the alignment of the Nε2 and 
Oε1 that allows for the formation of intermolecular hydrogen bonds. f, Top view of the 
fibrils showing the consistent side chain alignment down the length of the fibrils.  
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Figure 5.12 | Map of all SSNMR restraints onto the structure of a-syn fibrils. The 
backbone trace is shown in grey, black lines represent completely unambiguous distance 
restraints. Blue lines correspond to the shortest observed distance out of all possible 
assignments for ambiguous long-range restraints. The resulting structure is the only 
option consistent with all of the data. 
 
Figure 5.13 | Ramachandran plot of observed dihedral angles in the a-syn fibril 
structure. Ramachandran probability maps of accepted dihedral angle regions based on 
Lovell et al.61 and plotted in Chimera62 for residues 41-100, which are in the structured 
core. a, Plot of all non-glycine dihedral angles in residues 41-100. The only residue 
which is not in the accepted range is E57, which is a consequence of being unrestrained 
in the simulated annealing calculations. b, The plot of all glycines in residues 41-100. 
Non of the glycine residues are outside of the accepted Ramachandran space for glycines. 
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Figure 5.14 | Validation of α-syn fibril structure by microscopy and fiber 
diffraction. a, Bright-field of negatively stained TEM samples (left) and dark-field 
unstained STEM (right). Single-headed arrows indicate examples of fibrils. Double-
headed arrows indicate tobacco mosaic virus (TMV) rods, an internal control for mass-
per-length ratio. Insets are of higher magnification of the same samples. b, Histogram of 
the distributions of the STEM MPL measurement of unstained, freeze-dried, α-syn 
fibrils. c, Fiber diffraction pattern from α-syn fibrils. Black arrow indicates the cross-β 
meridional diffraction near 4.8 Å resolution. White arrow indicates strong peaks on the 
equator corresponding to an average β-sheet separation of 9.1 Å. 
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Figure 5.15 | Confirmation of fibril form for electron microscopy. a, Chemical shift 
comparison of the fibrils as prepared for solid-state NMR and after washing with HEPES 
buffer for electron microscopy. b, Expansions of overlaid 13C13C 2D’s of U-13C, 15N a-
syn fibrils as previously prepared for solid-state NMR (red) and fibrils washed with 
HEPES buffer as the samples for electron microscopy (blue). These results validate that 
no structural differences were present for the fibrils used for STEM compared to those 
used in the NMR studies. Spectra were acquired at 600 MHz 1H frequency, 13.3 kHz 
MAS and 50 ms DARR mixing. 
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CHAPTER 6: 
VALIDATION OF THE α-SYNUCLEIN FIBRIL STRUCTURE 
THROUGH MUTAGENESIS 
 
6.1 Notes and Acknowledgements 
This chapter is adapted from a manuscript in preparation. Authors include Marcus D. 
Tuttle, Joseph M. Courtney, Andrew J. Nieuwkoop, Shin. W. Lee, Jae K. Kim, Deborah 
A. Berthold, and Chad M. Rienstra. This work was supported by the National Institutes of 
Health (R01-GM073770). Marcus Tuttle was supported by the NIH Molecular 
Biophysics Training Grant at the University of Illinois at Urbana-Champaign (PHS 5 T32 
GM008276). Figure 6.1 is adapted with permission from Cell Press. 
6.2 Abstract 
The primary component of the pathological aggregates of PD is the protein α-
synuclein (α-syn) in a misfolded fibrillar state. Recent studies have identified multiple 
fibril polymorphs that exhibit different pathological behavior in in vitro studies, and have 
different structures as identified by solid-state NMR spectroscopy. With this increasing 
number of potentially relevant α-syn fibril structures and the traditionally extensive 
manual analysis required to obtain de novo structures of amyloid fibrils, there is a 
tremendous need for new methodologies that allow us to validate and compare α-syn 
fibril structures without obtaining full, atomic-resolution structures. Here we present an 
objective method of comparing SSNMR spectra of different α-syn fibrils and compare 
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the wild-type structure to a series of mutants that validate the wild-type structure and give 
details as to structural features that are important to fibril stability. 
6.3 Introduction 
Parkinson’s Disease (PD), the second most common neurodegenerative disease, is 
pathologically characterized by the intracytoplasmic aggregates Lewy Bodies (LBs) and 
Lewy Neurites (LNs)1. The primary component of these aggregates is the protein α-
synuclein (α-syn) in a misfolded fibrillar state2. Previous studies have established a strong 
connection between α-syn fibrils and PD pathology, showing that inoculation of 
exogenous pre-formed fibrils into non-transgenic mice causes recruitment of native 
mouse α-syn to form aggregates and initiate PD-like symptoms in mice3,4 and that 
different strains of α-syn fibrils have different pathology in neuronal cell culture models5.  
Understanding this link between α-syn fibrils and disease pathology could allow for a 
better understanding of PD and allow for the design of new biomarkers and treatments. 
Magic-angle spinning (MAS) solid-state NMR (SSNMR) spectroscopy has 
proven itself to be an invaluable tool for the study of amyloid fibril structure, including 
atomic-resolution structures of amyloid-β6-10, Het-S11,12, and β2-microglobulin13. 
SSNMR spectroscopy has allowed the identification of several α-syn fibril polymorphs 
through chemical shift and secondary structure analysis14-17, and in Chapter 5 we 
presented the first atomic-resolution structure of an α-syn fibril form that exhibits robust 
pathology in primary neuronal cell culture. This first structure establishes many key 
structural features we expect to be present in α-syn fibril structures, but it is increasingly 
evident that gaining an understanding of the differences in the structures of these fibril 
polymorphs will be vital in truly understanding the link with PD pathology. With the 
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increasing number of potentially relevant α-syn fibril structures and the traditionally 
extensive manual analysis required to obtain de novo structures of amyloid fibrils, there is 
an urgent need for new methodologies that allow us to validate and compare α-syn fibril 
structures without obtaining full, atomic-resolution structures. Here we present an 
objective method of comparing SSNMR spectra of different α-syn mutants, including the 
early-onset PD mutants, adapted from the recent COMPASS algorithm18 developed in 
our lab to compare predicted protein structures to experimental SSNMR data, to compare 
the spectra of the early-onset PD mutants A30P19, E46K, and A53T20 to the structure of 
WT fibrils previously reported. We then further show that non-native cysteine mutants at 
T33C, V48C, T59C, A85C, and Q99C further validate the structure of α-syn and 
establish cysteine mutants that would be good candidates for spin labeling for 
paramagnetic relaxation enhancement SSNMR studies. 
6.4 Results 
6.4.1 Adaptation of the COMPASS algorithm for comparing SSNMR spectra 
The comparative, objective, measure of protein architectures by simulated spectra 
(COMPASS) method previously published by our lab is a general protocol for comparing 
and predicting protein structure by comparing experimental NMR data to simulated data 
generated from a series of candidate structures18. Candidate structures that have simulated 
spectra most similar to the experimental spectra have lower COMPASS scores and are 
used as models for the true spectra (Fig 6.1). In the present case, our objective is to 
objectively compare two spectra from different proteins, in this case mutants of the same 
protein, and determine how similar the mutants are to the reference structure. In 
traditional NMR studies, differences in protein structure are determined by calculating 
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the RMSD between the assigned shifts of the two proteins. While this comparison is 
highly valuable by giving site-specific differences, it is a time consuming process subject 
to user subjectivity in peak picking and analysis. Alternatively, in the algorithm used here, 
we use a reference spectrum of the wild-type α-syn fibril of known structure, and 
calculate the COMPASS score with the mutant spectra. This score gives a total 
measurement of the degree of similarity between the spectra, and in the case of 
comparing mutants, gives a measure of the degree of structural perturbation induced by 
the mutant.  
6.4.2 Comparison of Early-Onset PD Mutants to the wild-type structure 
13C-13C , 15N-13C-13C and 13C-15N-13C21,22 correlation spectra of uniformly 13C-15N 
wild-type A30P, E46K, and A53T α-syn fibrils were collected with 50 ms DARR23 
mixing at 750 MHz 1H frequency (mutant locations shown in Fig. 6.2). These 
experiments allowed for the verification of the chemical shifts of the wild-type and 
familial mutants when compared to the previously published chemical shifts19,20. Peaks 
for the COMPASS analysis were picked in the 13C-13C correlation spectra (Fig 6.3) at 6 
σ and were subsequently filtered to remove the diagonal peaks and to ensure that peaks 
were present on both sides of the diagonal to within 0.4 ppm (approximately the 
linewidth) to remove noise peaks. The COMPASS score was then calculated between the 
reference wild-type spectrum and each of the familial mutants (Table 6.1). We calculated 
COMPASS scores of 1.25 for A30P, 1.60 for E46K and 1.35 for A53T, suggesting that 
E46K has the most significant structural differences  relative to the wild-type structure, 
consistent with the previously reported chemical shifts. COMPASS is a relative score, 
depending on the reference spectrum and the protein; achieving good agreement between 
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two spectra relies on a normalization procedure. In this case, the assigned chemical shifts 
of A30P act as a control, as they have been shown to be of extremely high similarity to 
the wild-type spectrum and show that A53T shows only slightly more spectral 
perturbations than A30P, as was proven by the site-specific assignments previously 
published. 
6.4.3 Selection and preparation of non-native cysteine mutants of α-syn fibrils 
Locations for cysteine mutants were chosen on the basis of the wild-type structure 
with the objective of identifying three sets of proteins:  (1) Mutation sites that did not 
perturb the structure of the protein, (2) Mutations that greatly perturbed the structure, (3) 
Mutations that were in proximity to the core but still maintained the structure. For set (1), 
the residues T33C and Q99C were prime examples of residues that, while near the core of 
the fibril, are in disordered border regions between the core and the disordered termini 
(Fig 6.4b and c). It was predicted that these mutants would have little impact on the 
chemical shifts of the protein, and structure would be maintained. For set (2), V48 was 
chosen for its involvement in the close backbone-backbone interactions between the 40s 
and the 70s in the structure (Fig 6.4b and c). We predicted significant chemical shift 
perturbations for nearby residues and a significant disruption of the structural interaction. 
For set (3), A85C and T59C were chosen as prime candidates for structural validation, as 
they are located in loops within the structure that we predicted would have the 
conformational freedom to allow the mutant (Fig 6.4b and c).  
Uniformly 13C-15N preparations of these mutants were then prepared and labeled 
with 1-Acetyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl-methanethiosulfonate (dia-
MTSL) (Fig. 6.4a) to mimic the paramagnetic tag commonly used in EPR and 
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paramagnetic relaxation enhancement SSNMR studies24 and study the impact these tags 
have on protein structure. Fibrils were grown of each fibril, and after three weeks fibrils 
were harvested as previously described. Interestingly, the V48C sample had not produced 
and quantifiable concentration of fibrils after 3 full weeks of incubation, at which point a 
majority of the protein has been incorporated into fibrils during a standard preparation. 
These samples were allowed to fibrillize for an additional two weeks, after which point 
no fibrils had formed, suggesting that the V48C sample disrupted the fibril structure to 
the point where viable fibrils were not capable of forming. 
6.4.4 Comparison of the cysteine mutants to the wild-type structure. 
13C-13C correlation spectra of each mutant were collected at 600 MHz 1H 
frequency with 50 ms DARR23 mixing (Fig. 6.5). As before, the peaks for the COMPASS 
analysis were picked at 6 σ and were filtered to remove the diagonal peaks and to ensure 
that peaks were present on both sides of the diagonal to within 0.4 ppm (approximately 
the linewidth) to remove noise peaks. We measured the COMPASS scores for each 
mutant compared to the same wild-type spectrum described in the case of the familial 
mutants (Table 2). We measured values of 0.94 for T33C, 0.92 for T59C, 1.53 for A85C, 
and 1.20 for Q99C, indicating that T33C, T59C, and Q99C are all highly similar to the 
wild-type spectrum (when compared to the score of 1.25 for the highly similar A30P), 
while A85C shows significant perturbations, with a score nearing that of E46K, the 
mutant that showed the most perturbations in site specific assignments. 
6.5 Discussion 
 The COMPASS scores comparing the spectra of the cysteine and familial mutants 
identified that the mutants, in order from most similar to least, were T59C, T33C, Q99C, 
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A30P, A53T, A85C, and E46K. Interestingly, the cysteine mutants, in most cases, appear 
to maintain the same overall fold to a higher degree than the familial mutants. This is 
quite surprising when compared to A30P – which has been shown to have nearly 
identical chemical shifts to those of the wild-type protein (Fig. 6.6). Visual inspection of 
the spectra with A30P, T33C, and T59C show that it appears A30P and T59C have the 
greatest agreement with the wild-type spectrum which is consistent with the previously 
assigned chemical shifts (Fig. 6.6). When mapped on to the fibril structure, it is evident 
that the structure is conserved in A30P and A53T, while E46K has large perturbations 
(Fig. 6.7). It is likely that the precise comparison between the samples could potentially 
be greatly impacted by experimental features such as line width or homogeneity, and it is 
likely that there are subtle effects, such as signal-to-noise ratio of the spectra, that can 
indirectly influence the COMPASS scores.  
 These COMPASS scores for the mutants also serve as a confirmation of the wild-
type α-syn fibril structure. In the cases of T33C, T59C, and Q99C, our initial hypothesis 
that they would cause few structural perturbations were confirmed, and highlight these 
mutants as potential choices for further structural studies such as the use of a 
paramagnetic tag for distance measurements24,25. V48C, while predicted to cause large 
structural perturbations, was surprisingly detrimental to the ability of α-syn to fibrillize 
despite being located outside the non-amyloid component of the fibril. It is possible that 
the mutation at V48C causes the fibrils to be trapped in some intermediate soluble state 
that prevents the formation of mature fibrils. A85C caused surprisingly large 
perturbations to the core structure – potentially by removing a residue with a small 
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sidechain that may be important in the formation of the inner turn of the Greek-key 
topology, causing perturbations throughout the core.  
 The lack of fibrillization of V48C and the large degree of perturbations between 
A85C and the wild-type spectra have large potential implications in the use of nitroxide 
spin labeles, such as S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl 
methanesulfonothioate (MTSL)24, for the use of EPR and PRE measurements via NMR. 
These measurements require the introduction of a spin label such as MTSL to measure 
the influence the unpaired electron has on the signal. In the case of PRE NMR, the 
measurement of relaxation rates can give distance restraints between the paramagnetic 
tag and the remaining nuclei in the protein; the impact the electron has on the relaxation 
rate is quantitatively related to the distance between the electron and nuclei. However, if 
there is a large structural perturbation from the introduction of the spin label, these 
distances may no longer relate to the true underlying structure, and can lead to misleading 
results. This problem is potentially compounded in the case of EPR, which frequently 
uses multiple cysteine mutants to introduce pairs of unpaired electrons to utilize 
techniques such as double electron-electron resonance (DEER). In these cases, not only 
may large structural perturbations be introduced by multiple spin labels, but there is a 
lack of atomic-level conformation that the structure is the same between the wild-type 
and mutant samples. It is clear that significant controls, such as the acquisition of 
correlation spectra and comparison via this COMPASS method, are crucial for ensuring 
that cysteine mutated proteins maintain the wild-type structure. 
 Here we have presented a proof of principle method for objectively comparing 
spectra from across many different mutants to show the degree of structural perturbations 
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induced by the mutant. While there are possible improvements to be made to this method, 
such as a normalized version of the scoring function that allows for comparison between 
different reference spectra, this approach begins to address a long-standing dichotomy in 
the NMR literature where spectra are either quantitatively compared by complete 
chemical shift assignments or by expert knowledge in the cases where chemical shifts are 
lacking. This new method allows for a fast, but reliable, comparison between NMR 
spectra, and could be used for additional applications such as confirmation of sample-to-
sample homogeneity and sample integrity over time.  
 
6.6 Materials and Methods 
6.6.1 Mutant Plasmid Construction 
 The α-synuclein gene was subcloned from pET28-AS by enzyme digestion with 
XbaI and HindIII. The α-synuclein DNA fragment was inserted into pUC19 via ligation. 
The ligation products were transformed in E. coli DH5α cells received from Invitrogen 
(Carlsbad, California). The transformed cells were plated on Luria Broth (LB) agar plate 
containing 100 µg/mL ampicillin. A colony from the LB agar plate was used to inoculate 
2.5 mL of LB containing 100 µg/mL ampicillin and the culture was grown overnight at 
37 ºC. The cells were pelleted by centrifugation for 2 minutes at 14,000 rpm and 4 °C. 
Plasmids were isolated using either the Qiagen Plasmid Mini Kit or Qiagen Plasmid Midi 
Kit (Valencia, California). Mutants A85C, T33C, T59C, V48C and Q99C were 
constructed using polymerase chain reaction (PCR). Two templates of pUC19-AS-wt 
were linearized with XbaI and HindIII, respectively. The Touchdown PCR method was 
used to construct the desired mutation. PCR solutions were prepared with a series of 
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Mg++ concentrations (1 mM, 1.5 mM, 2 mM, and 2.5 mM) for each reaction. ScaN and 
the antisense primers (AS_T33.R, AS_T59.R, AS_A85.R, and AS_Q99C.R) were added 
to the plasmid digested with HindIII. ScaC and the sense primers (AS_T33C.F, 
AS_T59C.F, AS_A85C.F, and AS_Q99C.F) were added to the plasmid digested with 
XbaI. 
6.6.2 Expression and Purification 
 The α-syn cysteine mutants were expressed in uniformly 13C, 15N isotopically 
labeled media as previously described using the mutant plasmids. The purification has 
been modified from Kloepper, et al. (2006)13 to adjust for the presence of cysteine in the 
α-synuclein sequence. The cell pellet from a one-liter culture expression was resuspended 
in 170 mL of lysis buffer (10 mM Tris-HCl, pH = 8.0, 1 mM ethylenediaminetetraacetic 
acid (EDTA), 40 mM NaOH, and 0.1% Triton X-100) and incubated in 37 ºC for 35 
minutes. Afterwards, 11 mM CaCl2, 11 mM MgCl2, and 300 U of DNase (New England 
BioLabs) were added and the mixture was shaken at 300 rpm at 37 ºC for an hour to 
degrade bacterial DNA and precipitate cell debris. EDTA was added to a final 
concentration of 5 mM, to remove excess metal. To remove cell debris, the mixture was 
centrifuged for 15 minutes at 10,000 g. The supernatant was collected and NaCl was 
added to a final concentration of 0.7 M. The solution was boiled for 15 minutes, 
incubated in ice water for 15 minutes, and centrifuged for 30 minutes at 10,000 g. The 
supernatant containing the protein was mixed with the same volume of saturated 
(NH4)2SO4 and incubated at 4 ºC overnight with stirring, to precipitate out α-synuclein. 
 The next day, the solution was centrifuged for an hour at 10,000 g to pellet the 
protein. The supernatant was passed through a 0.22 µm bottle top filter to catch any 
! 106!
precipitated, but unpelleted protein. The pellet was resuspended with 20 mM sodium 
phosphate buffer, pH = 7.4, and passed through the same filter to solubilize the trapped 
protein. To reduce the thiol groups on the cysteine, 20 mM DTT was added to the protein 
solution and incubated for an hour at room temperature. The protein was loaded onto a 
XK 26/20 Butyl Sepharose 4 Fast Flow hydrophobic interaction column (HIC) using an 
Akta Basic Fast Protein Liquid Chromatography system (FPLC) (GE Healthcare, 
Piscataway, NJ). The protein was eluted with a salt gradient from 1.4 M to 0 M 
(NH4)2SO4 in 20 mM sodium phosphate buffer. The protein was collected in 10 mL 
fraction collecting tubes. 
 The fractions containing α-synuclein were pooled and concentrated with a 3 kDa 
Millipore stirred cell and incubated with 20 mM DTT for an hour at room temperature to 
reduce cysteine that might have formed disulfide bonds during concentration. The protein 
was passed through a 0.22 µm syringe filter and loaded onto HiPrep 26/60 Sephacryl S-
200 High Resolution gel-filtration column. This chromatography was run in TEN buffer 
(150 mM NaCl, 1 mM EDTA, 10 mM Tris-HCl, pH = 8) with 1 mM DTT. The fractions 
containing α-synuclein were concentrated using a 3 kDa Millipore stirred cell 
concentrator. 
6.6.3 Labeling of Cysteine Residues 
 Purified α-synuclein was concentrated to about 40 mg in 2.5 mL (1.1 mM) to 
yield 25 mg of α-synuclein for spin labeling. DTT (11 mM) was added and incubated at 
42 ºC for an hour to ensure that all thiol groups were free for spin labeling. DTT was then 
removed via running the protein through a PD-10 buffer exchange column. α-Syn was 
then labeled with the diamagnetic tag 1-Acetyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-
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methyl-methanethiosulfonate (dia-MTSL) dissolved in 40% methanol. The sample was 
incubated at room temperature for 2 hours while shaking.  
6.6.4 Solid-State NMR Spectroscopy 
Magic-angle spinning (MAS) solid-state NMR experiments were conducted at 14.1 
T (600 MHz) and 17.6 T (750 MHz) on Agilent Technologies VNMRS (500 and 750 
MHz) and InfinityPlus (600 MHz) spectrometers using 3.2 mm Balun probes. Spinning 
was controlled with a Varian MAS controller to 11,111 ± 3 Hz (500 MHz 1H frequency), 
10,000 kHz or 13,333 kHz (600 MHz 1H frequency), and 12,500 Hz (750 MHz 1H 
frequency). Typical pulse widths after optimization were ~2-2.5 µs for 1H, ~3 µs for 13C, 
and ~5 µs for 15N. We used 75-80 kHz SPINAL decoupling during evolution and 
acquisition26.  Experiments were performed at a variable-temperature (VT) setting of 10 
°C, which is calibrated by ethylene glycol to a sample temperature of 12-17 °C. Chemical 
shifts were externally referenced using adamantane with the downfield peak set to 40.48 
ppm27. Chemical shifts for each sample were confirmed to agree with those previously 
reported14 using 2D 13C-13C, 3D 15N-13C-13C, 13C-15N-13C and 13C-13C-13C correlation 
experiments. 
6.6.5 Solid-State NMR Data Processing 
Spectra were processed with NMRPipe28 with back linear prediction with a 
polynomial baseline correction to the first dimension. Lorentzian-to-Gaussian 
apodization, cosine bells, and/or zero filling were applied in each dimension prior to 
Fourier transformation. The spectra were analyzed in Sparky29. COMPASS scores were 
calculated as described by Courtney et al.. !  
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6.7 Figures 
 
 
 
Figure'6.1'|'Flow'Chart'of'the'COMPASS'Algorithm.!(A)!The!algorithm!takes!as!input!a!13C@13C!correlation!spectrum.!A!selected!region!for!a!spectrum!of!ubiquitin!is!shown.!(B)!The!peaks!are!enumerated!and!stored!as!a!list!of!unassigned!chemical!shift!pairs.!(C)!A!collection!of!test!models!is!produced.!The!model!shown!was!generated!by!MODELLER!and!has!a!Cα!RMSD!of!8.5!Å!with!respect!to!the!reference!structure,!PDB:!1UBQ.!(D)!The!chemical!shifts!for!each!model!are!predicted!by!SHIFTX2,!and!a!list!of!peaks!that!would!occur!in!a!13C@13C!correlation!spectrum!is!generated.!(E)!The!experimental!and!model!peak!lists!are!compared!using!the!COMPASS!score.!Blue!lines!indicate!the!minimum!distances!described!in!the!text.!(F)!In!this!example!the!COMPASS!score!from!the!experimental!peak!list!to!the!model!is!0.902!ppm!(point!indicated!with!blue!arrow),!a!relatively!high!value.!The!models!are!then!ranked!in!the!order!of!their!computed!COMPASS!score.!!!Figure!and!Caption!from!Courtney!et#al.#Structure!23:10!1958@1966!(2015)!with!permission!from!Cell!Press!!
' '
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Figure 6.2 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. 
 
 
 
 
Figure 6.3 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. 
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Figure 6.4 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. 
 
 
 
 
Figure 6.5 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. !  
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Figure 6.6 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. !  
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Figure 6.7 | 13C, 13C SSNMR {1H}-13C-{1H-1H}-13C data showing unambiguous 
intramolecular long-range correlations. 2D MAS solid-state NMR spectrum of dilute 
a-syn fibrils acquired at 750 MHz 1H frequency, 12.5 kHz MAS and 400 µs 1H-1H 
mixing. Red labels correspond to unambiguous long-range distances. Data required signal 
averaging for 12 days. 
 
6.8'Tables'
 
Table 6.1 | COMPASS scores comparing each familial mutant spectrum to the wild-
type spectrum. 
Mutant COMPASS Score 
A30P 1.25 
E46K 1.60 
A53T 1.35 
 
 
Table 6.2 | COMPASS scores comparing each cysteine mutant spectrum to the wild-
type spectrum. 
Mutant COMPASS Score 
T33C 0.94 
T59C 0.92 
A85C 1.53 
Q99C 1.20 
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CHAPTER 7: 
COMPUTATIONAL ROBUSTNESS OF SSNMR PROTEIN 
STRUCTURES 
 
7.1 Notes and Ackowledgements 
The work presented in this chapter is a work in preparation with equal contribution 
from Joseph Courtney and in collaboration with an undergraduate student Ryan Russell. 
This work was supported by the National Institutes of Health (R01-GM073770, P50 
NS053488, P01 AG002132). Marcus Tuttle was supported by the NIH Molecular 
Biophysics Training Grant at the University of Illinois at Urbana-Champaign (PHS 5 T32 
GM008276). A portion of the research was performed in the Environmental Molecular 
Sciences Laboratory, a national scientific user facility sponsored by the Department of 
Energy's Office of Biological and Environmental Research and located at Pacific 
Northwest National Laboratory. 
7.2 Abstract 
The RCSB PDB has had over 11,000 structures deposited since the first structure 
solved by NMR was submitted to the PDB in 1986. Despite this enormous success of 
NMR spectroscopy as a method for determining protein structures, reproducibility of the 
structure calculation process remains challenging. Most NMR structures are solved 
through the combination of extensive manual analysis and computational methods, and 
subjective analysis of the data is a concern in structure validation of NMR structures.  
Unlike in X-ray crystallography, there is no measure such as Rwork to compare the 
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agreement between the structure and raw experimental data. Here we present an initial 
measure of the agreement between structure and unassigned NMR spectra and propose 
future applications and extensions of this measure to develop a universal approach to 
confirm the quality, validity, and consistency of NMR structures. 
 
7.3 Introduction 
Almost every year there are new reports, papers, and editorials on the problems with 
reproducibility in science1 and with the increasing amount of experimental data and 
manual, sometimes subjective, and computational analysis used in modern research, 
validation of work via repetition of the work by other research groups is in most cases 
prohibitively time consuming. Addressing these concerns is a crucial problem moving 
forward in scientific research. One appealing approach is the development of objective 
analysis and validation techniques for experimental results that are most susceptible to 
error.  
Since its first success in solving a protein structure in 1986, NMR spectroscopy has 
established itself as an invaluable tool for structural studies of biomolecules, with more 
than 11,000 structures (~10%) of the PDB being contributed by NMR2. However, the 
process of solving an NMR structure usually requires extensive manual analysis of 
experimental data, and the opportunity for subjective conclusions to give rise incorrect 
conclusions when compared to electron density maps in X-ray crystallography. 
Additionally, the measure Rwork3 developed for X-ray crystallography is a direct measure 
of the agreement between the structure and the X-ray diffraction data. A similar objective 
metric is distinctly lacking in NMR, where the only major validation tool compares the 
structure to the manually assigned distance restraints, which may inherently already 
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include experimental errors introduced at the stage of manual peak picking analysis. 
While tools such as the Protein Structure Validation Software suite (PSVS)4 are useful 
for catching major errors in protein folds, such as Ramachandran violations and van der 
Waals clashes, NMR lacks a universally accepted measure of comparison of the structure 
to the initial experimental data. Here, we present the first attempt to develop a measure of 
agreement between the protein structure and the experimental data by measuring 
distances within the structure and comparing them to unassigned NMR spectra to 
determine how much of the experimental data is explained by the structure. 
 
7.4 Methods and Results 
7.4.1 Algorithm for structure validation 
The goal of the algorithm is to develop a process where we can take an NMR derived 
structure and compare simulated experimental data from the structure with the 
experimental structure. Because a majority of the data used in structure determination is 
based on distances between nuclei, we can take the structure and measure all atoms 
within a certain distance of a nucleus. By taking all atom-pairs within a certain distance 
bound, such as 6 Å, we can then correlate the atom-pairs with the assigned chemical 
shifts for the protein and generate an idealized peak list for all possible observable 
distances consistent with the structure. We can then match all of the peaks from an 
experimental spectrum in an automated method, avoiding the requirement of manual 
analysis, and find experimental peaks that are within error consistent with the observed 
distances in the protein. This list of peaks consistent with the structure could then be used 
as a metric for such purposes as structure validation (by comparing the total number of 
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peaks to the total number of assignable peaks), confirm the chemical shift assignments 
similarly by the degree with which the experimental and theoretical peak lists match, and 
even generate lists of long-range distance restraints that are consistent with the structure. 
This algorithm is summarized in a flow chart in Fig. 1. For the initial test of this approach 
as a structural validation method, we can simply compare the number of assignable peaks 
to the total number of peaks present in the spectrum.  
7.4.2 Test of algorithm on well-known structure of GB1 
The model protein GB1 has the highest resolution structure of a protein solved by 
solid-state NMR spectroscopy5 and has been completely assigned in previous reports and 
makes an ideal case for testing the completeness of assignability of a NMR spectrum 
using the structure as a filter. A 13C-13C correlation spectrum of a uniformly 13C-15N 
labeled GB1 sample was acquired at 750 MHz 1H with 500 ms of DARR6 mixing, 
yielding a large number of long-range restraints observed in the data. The spectrum was 
then automatically peak-picked in Sparky7 at 6 σ and the peaks exported, using a Python 
utility. Atom pairs were calculated for all carbon atoms from the SSNMR structure (PDB 
accession code 2LGI) for 4, 6, 8, and 10 Å to empirically determine which distance 
bound gives the highest matching with experimental data. Simulated peaks were 
generated from the spectrum and then matched to the experimental spectrum within 0.2 
ppm from the predicted value. We observed an increasing number of assignable peaks as 
the distance bound was increased from 4 to 10 Å, observing only 4% of the peaks being 
assigned at 4 Å, up to 71% of the peaks consistent with distances of up to 10 Å (Table 1).  
7.4.3 Results of algorithm on α-syn fibrils 
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Similarly to the test case of GB1, a 13C-13C correlation spectrum of a uniformly 13C-
15N labeled α-syn fibril sample was acquired at 900 MHz 1H with 250 ms of DARR 
mixing. The spectrum was peak-picked in Sparky at 6 σ and the peaks exported via 
Python. Atom pairs were calculated for all carbon atoms from the SSNMR structure 
presented in Chapter 5 for 4, 6, 8, and 10 Å to compare to the GB1 results above. 
Similarly to the case of GB1, we observe an increasing number of assignments from only 
4% at 4 Å, but the highest percentage of peaks assigned at 10 Å only corresponds to 36% 
of the total number of peaks in the spectrum. 
 
7.5 Discussion 
In an idealized situation, we could imagine that an NMR structure could account for 
the entirety of the peaks present in the spectrum.  In reality, there are several reasons that 
additional peaks might be observed, which are not predicted to be present based on the 
structure, and/or peaks not appear that are expected.  Additional peaks might arise, which 
are not predicted by the algorithm described above, due to: (1) experimental artifacts 
(including but not limited to quadrature images, baseline errors, spinning sidebands, and 
aliased peaks), (2) intermolecular correlations not predicted by the monomer structure, 
and/or (3) portions of the protein not initially assigned when generating the resonance 
list.  Peaks might be missing due to:  (1) low signal to noise ratio; (2) partial overlap with 
other peaks (causing a distortion in the peak positions); and/or (3) relaxation processes 
during long mixing time experiments that do not impact short mixing time data sets.  
In the case of GB1, a value of 71% is a surprisingly good value for this naïve measure 
which does not take into account signal-to-noise or overlap. As this algorithm is currently 
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dependent on the automated peak picking algorithm in Sparky (which has poor 
convergence properties with respect to picking of peaks in overlapped regions), there are 
likely many peaks that are not representative on individual spin systems. While it is likely 
that manual analysis of these peaks could alleviate part of this problem, this would 
introduce a more subjective peak picking procedure than the Sparky utility. 
The low convergence score of α-syn at only 36% is initially of concern as to the 
validity of the structure presented in Chapter 5. We attribute the major portion of the 
disagreement to the fact that only about half of the residues in α-syn are structured. In 
particular, significant portions of the N-terminus (residues 1 to ~40) have assigned 
chemical shifts have been assigned but do not exhibit any cross peaks in the spectra 
corresponding to long-range distances in the structure presented in Chapter 5. While 
restraints for this region were not manually assignable, it is possible that this region of the 
protein is interacting more tightly with the core, and these restraints are not matching in 
this algorithm.  One would expect the upper bound of agreement to correspond with the 
fraction of residues in a protein that are structured; in α-syn this is approximately 50%. 
Additional reasons for discrepancies between the computed and experimental cross 
peak patterns are as follows.  The α-syn structure is of much lower resolution than the 
GB1 structure (1.8 vs 0.23 Å) and this poorer quality structure is likely to have small 
errors in sidechain packing, and Van der Waal’s interactions that are not as close as they 
would be in the true structure – a common issue in NMR refined structures. Additionally, 
α-syn has unusually degenerate spectra due to the secondary structure and amino-acid 
degeneracy within the core. This problem likely contributes to mismatches between the 
experimental and theoretical peak lists, resulting in significantly lower scores for α-syn. 
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Another reason for this difference is likely that the experimental data set at 900 MHz was 
collected at significantly different magic-angle spinning rate and decoupling conditions 
than those data sets at 500 and 750 MHz used to determine the structure.  We plan to 
collect data at 750 MHz to address this issue. 
It is clear that additional development of this algorithm would be required to be used 
as a structure validation tool, as the reliance upon the automated peak picking routines 
introduce errors that make the interpretation of the results challenging. One possible 
approach to solve this issue is to use higher dimensionality data, such as 15N-13C-13C 
spectra, which are less likely to have poorly picked overlapped regions. Additionally, the 
percentage of assignable peaks will likely have a strong dependence on the size of the 
protein as was observed for the qualitatively similar COMPASS score published by our 
lab8. A method of normalization, such as a log-likehood calculation to determine the 
probability that the data came from the structure, would make the measure more 
universally applicable and comparable between different proteins. Nevertheless, this 
measure provides a first attempt at measuring structural completeness in an objective 
approach that gives a framework towards developing a better metric.  
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7.6 Figures 
 
Figure 7.1 | Flow chart representing the flow of analysis and the possible 
applications of the measure. 
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Figure 7.2 | 13C-13C correlation spectrum of uniformly 13C-15N labeled GB1 
collected at 750 MHz 1H frequency with 500 ms DARR mixing. The mixing time 
in this spectrum allows for the detection of a large number of peaks that are consistent 
with long-range correlations. 
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Figure 7.3 | 13C-13C correlation spectrum of uniformly 13C-15N labeled α-syn 
collected at 900 MHz 1H frequency with 250 ms DARR mixing. The mixing time 
in this spectrum allows for the detection of mostly near neighbor peaks with many 
additional peaks that are consistent with long-range correlations. 
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7.7 Tables 
Table 7.1 | Summary of GB1 peaks that are consistent with measured distances in 
the structure. 
Distance Bound Number of Peaks Assigned Percentage of total peaks 
4 Å 90 4% 
6 Å 764 34% 
8 Å 1292 58% 
10 Å 1592 71% 
Total 2221  
 
Table 7.2 | Summary of α-syn peaks that are consistent with measured distances in 
the structure. 
Distance Bound Number of Peaks Assigned Percentage of total peaks 
4 Å 65 4% 
6 Å 338 21% 
8 Å 515 32% 
10 Å 585 36% 
Total 1584  
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CHAPTER 8: 
CONCLUSIONS AND OUTLOOK 
 
8.1 Conclusions 
 The first atomic-resolution structure of α-synuclein fibrils has been obtained via 
solid-state NMR spectroscopy. Through the collection of thousands of hours of SSNMR 
data and extensive manual assignment of the spectra, a resulting in more than 7,500 
assigned crosspeaks, a convergent structure consistent with electron microscopy and X-
ray fiber diffraction results was achieved. Further, this fibril form shows robust pathology 
in primary neuronal cell culture and is consistent with prior fibril forms that exhibit 
Parkinson’s-like symptoms in mice and rodent models for Parkinson’s disease. Not only 
will this structure server as a starting point for determining additional pathologically 
important α-syn fibril structures, it will also serve as a basis for rational design of 
biomarkers and therapies and as an ideal test case for understanding fibril interactions 
with other biomolecules, such as small compounds and proteins, and give a deeper 
understanding of the processes of fibril nucleation, elongation, and propagation.  
 This fibril structure has predictive power in understanding the impact that point 
mutations have on the structure. Three of the early-onset PD mutants – A30P, E46K, and 
A53T all show chemical shift perturbations consistent with the fibril core, with A30P and 
A53T having littler effect on the structure, while E46K, disrupting a crucial salt-bridge, 
forms a fibril with different structural characteristics. This result hints that the possible 
cause of the early-onset PD may be related to a loss-of-function of native α-syn, which 
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has been postulated to cause an overexpression in α-syn, which could drastically increase 
the probability of a spontaneous nucleation event. Further non-native labeled cysteine 
mutagenesis of the core of α-syn, including T33C, V48C, T59C, A85C, and Q99, further 
validate the structure by showing that those residues on the fringe of the core (T33C and 
Q99C) or in highly disordered loops (T59C) appear to have little structural impact. 
Conversely, A85C, which is located in a structured loop, appears to have small 
perturbations, but otherwise maintains the same global fold. V48C, interrupting a close 
backbone-backbone interaction of two β-sheets with the high 70s so severely disrupts the 
structure that fibrils had not formed even within 3 weeks of incubation. 
 The work in this dissertation marks a turning point in our understanding of α-syn 
fibril structure, and presents the most comprehensive structural study of an α-syn fibril 
form presented to date. Through a combination of SSNMR methodologies, electron 
microscopy, X-ray fiber diffraction, and biophysical assays, we were able to obtain a 
structure of pathological importance that was revealed to be of significantly higher 
complexity than early predictions. With a backbone RMSD of 1.8 Å and validation 
through mutagenesis and computational spectral comparison, this structure is strongly 
supported by the data presented in this dissertation. Future progress in understanding the 
relationship between fibril structure and pathology will require additional structural 
studies of α-syn fibrils of different form, but will be able to significantly expand our 
understanding of PD. 
 
8.2 Outlook 
It is an extremely exciting era of research into neurodegenerative diseases, with a 
nearly simultaneous convergence of our ability to complete amyloid structures via 
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SSNMR spectroscopy that were once predicted to be intractable, with the biological 
research that has honed in on the experiments, assays, and animal models that allow us to 
test pathological hypothesis and treatments. Combining these areas of expertise, it is 
likely that our understanding of PD pathology as it relates to fibril structure is likely to 
rapidly expand, while simultaneous research into rational design of novel biomarkers 
may lead to earlier diagnosis of PD, a key first step in slowing or stopping the disease. 
8.2.1 α-syn fibril structure as a starting point for new fibril structures 
There have been at least 4 different forms of human α-syn fibrils presented in the 
literature1-4, all of which exhibit distinct secondary structure patterns. Recently, 
pathological data has shown that several of these different fibril forms, such as the 
“ribbons” and “fibrils” from Bousett et al.4 have significantly different pathology and 
morphologies, as evidences by SSNMR and electron microscopy data, while other reports 
have shown that even small conformational changes, as shown by Guo et al.5 can lead to 
different pathological features in cell culture. It is increasingly evident that different fibril 
polymorphs are important to PD, but the only atomic-resolution available to date is from 
the structure presented in Chapter 5 of this dissertation.  
While the full de novo structure calculation can take months to complete, a lot of 
structural information can be obtained via comparisons of SSNMR spectra of fibril forms 
of unknown structure to the fibril form presented in this work. For instance, as shown in 
Chapter 6, new cysteine mutants of α-syn presented chemical shift perturbations as 
evidenced by spectral changes measured by the COMPASS6 score, and it was possible to 
determine how similar the two folds must be. Further assignment of chemical shifts, as 
was done with the early-onset PD mutants further allows us to localize where structural 
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perturbations must be occurring, and where to focus structure determination efforts. 
Additionally, the structure in Chapter 5 establishes many key structural interactions 
including the salt-bridge, I88-F84 interactions, and the Q79 ladder that are likely to be 
present in new fibril forms and give a road map for the types of interactions that are 
likely to be conserved across the α-syn protomer core. 
8.2.2 Rational design and testing of α-syn fibril biomarkers 
An enormous unmet need in the area of amyloidogenic neurodegenerative 
diseases is the ability to detect and track disease from an early stage. The complete lack 
of clinical biomarkers for Lewy Bodies and α-syn fibrils results in the diagnosis of PD 
once symptoms have appeared in patients, often late enough in the disease to significantly 
hinder treatment. This unmet need is so crucial, that the Michael J. Fox Foundation, the 
largest private source of research funding for PD, has created the Parkinson’s Progression 
Marker Initiative and the Fox Investigation for New Discovery of Biomarkers research 
and clinical studies, dedicating more than $60 million dollars for each initiative with the 
sole purpose of developing a viable biomarker. However, efforts to develop selective, 
sensitive biomarkers for PD are often hampered by cross binding interactions with other 
amyloid fibril diseases, such as Alzheimer’s. In order to alleviate this problem, atomic-
resolution information on the binding interfaces will be crucial for developing more 
specific, higher affinity compounds. 
SSNMR studies combining these small compounds with fibrils of known 
structure, such as the one presented in this dissertation or through additional studies as 
described in 9.2.1 are capable of providing detailed binding interfaces between the 
compound and the fibril. Positron emission tomography imaging agents, such as the 
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phenothiazine synuclein imaging ligands recently reported by Bagchi et al.7, are ideal 
candidates for these structural studies, as the synthesis often allows for the incorporation 
of 13C or 19F which allow for the measurement of distances between the fibril and the 
small compound. In the case of 13C labeled small molecules, the techniques described in 
Chapter 3 to measure the intermolecular registry and architecture work extremely well, 
such as heteronuclear REDOR8 and TEDOR9 where the fibril is labeled with 15N, and any 
presence of 15N-13C correlations would correspond to binding of the small molecules to 
the fibril. 19F, in particular, is extremely well suited for studying these interactions. Its 
gyromagnetic ratio is 94% of that of 1H and is one of the most sensitive NMR nuclei. 
Combined with the low background of 19F in biological samples, any strong signal 
observed between the fibril and the small molecule, such as through 19F dephased 
REDOR shift (FRESH)10 spectroscopy will be clear, high signal-to-noise interactions 
between the protein and small molecule and protein. By understanding these binding 
interfaces, we will be able to determine what key interactions drive the binding, which 
may allow for the design of new biomarkers, or even compounds that are capable of 
blocking fibril elongation or propagation. 
8.2.3 Structure of α-syn fibrils isolated from PD patients 
While the structure presented in this work has been shown to be pathologically 
active in neuronal cell culture, previous research with amyloid-β fibrils has shown that 
the structure of in vitro fibrils prepared through incubation and agitation can be quite 
different from those that are isolated from Alzheimer’s disease (AD) patients. In the first 
structure of an amyloid fibril derived from brain tissue, Lu et al.11 showed that the 
structure of the AD tissue fibril depended upon the pathological progression of AD in the 
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patient. This result was the first indication that polymorphism existed not only in in vitro 
fibril samples, but also in vivo, and it is likely that similar observations will be true in the 
case of PD as well. While this landmark study of Aβ fibrils structure provides a clear 
protocol for preparing fibril samples for SSNMR spectroscopy from brain-derived tissue, 
the drastically lower of concentration of α-syn fibrils in PD patients presents a particular 
challenge for performing SSNMR spectroscopy on similarly prepared α-syn fibril 
samples. 
One possible approach to seeding in vitro prepared α-syn monomer to recreate the 
fold of the fibrils found in patient brain material would be to follow a modified form of 
the protein misfolding cyclic amplification (PMCA)12, the standard protocol used in 
detecting small quantities of misfolded prion protein. A typical PMCA protocol incubates 
a small amount of misfolded protein in a bath of unfolded monomer, and with agitation 
over time, the seed material induces misfolding in the unfolded monomer, and much like 
PCR, results in extreme amplification of the misfolded material. However, if there exists 
any small amount of pre-formed aggregates, such as may occur during protein 
purification, it could be possible to amplify the wrong form. An alteration to PMCA 
which would drive the fibrillization to adopt the structure of a small amount of pre-
formed fibril would be to add monomeric solutions at slowly increasing concentrations 
such that the concentration of unfolded protein is the same as folded fibrils, this ensures 
that the templating material (such as isolated fibrils from patient brains), would be the 
dominant species. This type of approach opens exciting opportunities to prepare samples 
that would determine the structure of α-syn fibrils related to different PD phenotypes. 
8.2.4 Solid-State NMR experiments to expedite the structure determination process 
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With the existence of multiple known polymorphs of α-syn fibrils, and the 
exciting prospects of samples prepared from PD tissue, the current number of eagerly 
awaited structures drastically outpaces the current ability to solve the structures with 
current standard methodologies. The structure in this dissertation was a multi-year project 
including early groundbreaking work by predecessors in the Rienstra lab that developed 
the sample preparation and SSNMR experiments required for chemical shift assignments 
and early structure model generation. While many of these results will be readily 
applicable to new samples, such as the sample preparation and SSNMR experiments that 
are best suited for detecting long-range restraints, the extremely time consuming manual 
analysis, chemical shift assignments, long-range restraint detection, and structure 
calculation iterations required to reach a convergent structure stills requires months to 
even years to complete. To enable better structure-function studies and comparisons of 
different forms of α-syn fibrils, it becomes evident that new methodologies for 
determining structures and streamlining analysis are crucial. 
Recent technical advances in the hardware available for SSNMR spectroscopy 
have provided opportunities to reliably achieve magic-angle spinning (MAS) rates of 
greater than 60 kHz13 utilizing small rotors requiring only a fraction of material (on the 
order of ~1 mg of protein). At these spinning rates, the MAS rates being tp approach the 
homonuclear 1H-1H dipolar couplings of ~122 kHz for 1H spins that are close in space. At 
spinning rates greater than ~20 kHz, the transverse relaxation rate (T2) is significantly 
enhanced and these fast MAS rates allow for the use of proton-detected SSNMR 
experiments14. The use of these small rotors at high spinning rates, combined with the 
significantly larger 1H gyromagnetic ratio when compared to carbon (4:1), allows for the 
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collection of high-sensitivity data on samples of significantly lower quantities, possibly 
enabling the determination of fibril structures from the smaller samples seeded from PD 
brain material. Additionally, dynamic nuclear polarization (DNP) SSNMR 
spectroscopy15, wherein polarization is transferred to NMR active nuclei from an 
unpaired electron through the Cross effect, could theoretically give enhancements of 
hundreds of orders of magnitude due to the electron gyromagnetic ratio being ~650 times 
larger than that of 1H. The exciting prospects of combining DNP with fastMAS SSNMR 
studies could potentially allow for the collection of data with very high signal-to-noise 
from minute quantities of protein to rapidly determine chemical shift assignments and 
long-range restraints. 
 Simultaneously with instrumental and hardware advances in SSNMR, developing 
computational methodologies for the collection, processing, and analyzing SSNMR data 
could further lessen the amount of significant signal averaging and extensive manual 
analysis required for structure determination. Recently, a labmate in the Rienstra lab, 
Joseph Courtney, developed and published a manuscript that presents the first case where 
it was possible to correctly determine the structure of a protein without complete 
chemical shift assignments, and without the detection and assignment of long-range 
structural restraints6. Utilizing recent advances in our ability to predict chemical shifts 
directly from a protein structure16, this technique allows us to form early structural 
models of proteins prior to measuring long-range restraints and guide the entire structure 
determination process, drastically shortening the time from first SSNMR spectra to 
structure. This new ideology is significantly different from the standard approach to 
solving structures, but hints at advances that may be made to further shorten the structure 
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determine process. Importantly, computational algorithms have long been sought that can 
accurately and reliably assign chemical shifts from experimental peaks without the 
traditional manual backbone-walk process, typically one of the longest stages in 
determining a structure. While, in theory, this computational approach would seem 
relatively easy to develop, the significant amount of overlap and low signal-to-noise of 
SSNMR spectra have made attempts at computationally assigning proteins work only in 
cases with exceptionally well-resolved data. However, recent reports on the use of a non-
dominated genetic algorithms to assign protein chemical shifts show early promise, and it 
is likely that these approaches may be refined in the near future17. Combined with our 
increased ability to predict chemical shifts and quickly compare shifts from simulated and 
experimental data (using the COMPASS score), it is likely that hybrid structure 
calculation programs, such as the newly release GAMDY18 software, will increase the 
capabilities to solve new α-syn fibril structures quickly in a more reliable and robust 
methodology. Combined with the validation approaches discussed in Chapter 7, it seems 
that structural biology through the use of NMR, especially SSNMR, are entering a 
potentially new era where structural information will be more accessible and allow for 
the study of increasingly complex systems, ranging not only from amyloid fibrils, but to 
other complex biological environments such as membrane proteins, lipid membranes, 
drug design, and at the interfaces between.  
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